NHS Connecting for Health
NHS Data Model and Dictionary Service
Type: | Patch |
Reference: | 1338 |
Version No: | 1.0 |
Subject: | November Release Patch |
Effective Date: | Immediate |
Reason for Change: | Patch |
Publication Date: | 20 November 2012 |
Background:
This patch updates the NHS Data Model and Dictionary in preparation for the November 2012 Release and includes:
- What's New amended to include Change Requests incorporated since the last version of the NHS Data Model and Dictionary was published
- Missing hyperlinks added
- Html format corrected.
To view a demonstration on "How to Read an NHS Data Model and Dictionary Change Request", visit the NHS Data Model and Dictionary help pages at: http://www.datadictionary.nhs.uk/Flash_Files/changerequest.htm.
Note: if the web page does not open, please copy the link and paste into the web browser.
Summary of changes:
Central Return Forms | |
KC62 A 1 | Changed Description |
KC62 A 2 | Changed Description |
KC62 A 3 | Changed Description |
KC62 ANNEX 1 | Changed Description |
KC62 B 1 | Changed Description |
KC62 B 2 | Changed Description |
KC62 B 3 | Changed Description |
KC62 C1 1 | Changed Description |
KC62 C1 2 | Changed Description |
KC62 C1 3 | Changed Description |
KC62 C2 1 | Changed Description |
KC62 C2 2 | Changed Description |
KC62 C2 3 | Changed Description |
KC62 D 1 | Changed Description |
KC62 D 2 | Changed Description |
KC62 D 3 | Changed Description |
KC62 E 1 | Changed Description |
KC62 E 2 | Changed Description |
KC62 E 3 | Changed Description |
KC62 F1 1 | Changed Description |
KC62 F1 2 | Changed Description |
KC62 F1 3 | Changed Description |
KC62 F2 1 | Changed Description |
KC62 F2 2 | Changed Description |
KC62 F2 3 | Changed Description |
KC62 T 1 | Changed Description |
KC62 T 2 | Changed Description |
KC62 T 3 | Changed Description |
Supporting Information | |
ABOUT US HELP | Changed Description |
GLOSSARY OF TERMS | Changed Description |
INDEX | Changed Description |
SAME SEX ACCOMMODATION | Changed Description |
SECURITY ISSUES AND PATIENT CONFIDENTIALITY | Changed Description |
SUPPORTING INFORMATION MENU | Changed Description |
WHAT'S NEW: NOVEMBER 2012 renamed from WHAT'S NEW: SEPTEMBER 2012 | Changed Name, Description |
Attribute Definitions | |
ACTIVITY DATE AND TIME TYPE | Changed Description |
ATTENDED OR DID NOT ATTEND | Changed Description |
CURRENCY TYPE | Changed Description |
LIVE OR STILL BIRTH | Changed Description |
MEASUREMENT VALUE TYPE CODE | Changed Description |
ORGANISATION CODE | Changed Description |
ORGANISATION SITE CODE | Changed Description |
PATIENT DIAGNOSIS TYPE FOR NHS HEALTH CHECK | Changed Description |
Data Elements | |
ABSENCE WITHOUT LEAVE END DATE (RETIRED) renamed from ABSENCE WITHOUT LEAVE END DATE | Changed Name, status to Retired, Description |
ABSENCE WITHOUT LEAVE START DATE (RETIRED) renamed from ABSENCE WITHOUT LEAVE START DATE | Changed Name, status to Retired, Description |
ACTIVITY TREATMENT FUNCTION CODE | Changed Description |
ASSESSMENT DATE (FOR TRANSPLANT SUITABILITY) | Changed Description |
CDS RECORD IDENTIFIER | Changed Description |
COMMISSIONER OR PROVIDER STATUS INDICATOR | Changed Description |
COMMISSIONER REFERENCE NUMBER | Changed Description |
COMMISSIONING SERIAL NUMBER | Changed Description |
EARLIEST CLINICALLY APPROPRIATE DATE | Changed Description |
END TIME (SUPERVISED COMMUNITY TREATMENT RECALL) | Changed Description |
LEAVE OF ABSENCE END DATE (RETIRED) renamed from LEAVE OF ABSENCE END DATE | Changed Name, status to Retired, Description |
LEAVE OF ABSENCE START DATE (RETIRED) renamed from LEAVE OF ABSENCE START DATE | Changed Name, status to Retired, Description |
OPERATION STATUS CODE | Changed Description |
PASSPORT NUMBER (OLD) | Changed Description |
PERSON BIRTH DATE | Changed Description |
PERSON BIRTH DATE (BABY) | Changed Description |
PERSON BIRTH DATE (MOTHER) | Changed Description |
PERSON HEIGHT IN CENTIMETRES | Changed Description |
PERSON HEIGHT IN METRES | Changed Description |
RENAL TREATMENT MODALITY NO TREATMENT REASON DATE | Changed linked Attribute |
Packages | |
NE renamed from NE | Changed Name |
OC renamed from OF | Changed Name |
Date: | 20 November 2012 |
Sponsor: | Richard Kavanagh, NHS Connecting for Health |
Note: New text is shown with a blue background. Deleted text is crossed out. Retired text is shown in grey. Within the Diagrams deleted classes and relationships are red, changed items are blue and new items are green.
Click here for a printer friendly view of this page.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table A: 1st Invitation for Routine ScreeningThis table reports the persons in aScreening Programme(seePERSON IN PROGRAMME) for Breast Screening whoseSCREENING STATUSisfirst call.Part A1: Invitations and Outcomes- This table reports the persons in a Screening Programme (see PERSON IN PROGRAMME) for Breast Screening whose SCREENING STATUS is first call.
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS BreastScreening Programmetarget age range of 50 to 70 - theScreening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.This is derived from the PERSON BIRTH DATE of the PERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.
Lines 13 - 24 in Part A2 Assessment and lines 25 - 36 in Part A3 Cancer diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of Screening Test Invitations where the first Screening Test Invitation has a first test date offered (see APPOINTMENT DATE OFFERED) in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL REQUEST for breast assessment was made.
Number screened (technically adequate) (column 3)
Count of women with a Screening Test Date in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid Screening Test Date but where no breast cancer screening test outcome (see BREAST ASSESSMENT OR TEST OUTCOME) has been recorded.
Outcome of initial screen: Routine recall (column 5)
- Count of women with a breast cancer screening test outcome classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a breast cancer screening test outcome classification of Early recall but without a REFERRAL REQUEST for breast assessment.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL REQUEST for breast assessment. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL REQUEST for breast assessment who failed to attend for all required assessment appointments and for whom there is no breast assessment final outcome (see BREAST ASSESSMENT OR TEST OUTCOME).
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a breast assessment date (see ACTIVITY DATE) but where no breast assessment final outcome has been recorded.
Final outcome of assessment: Routine recall (column 10)
Count of women with a breast assessment date and a breast assessment final outcome classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a breast assessment date and a breast assessment final outcome classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a breast assessment date and a breast assessment final outcome classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part A2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a breast assessment date and a breast assessment final outcome classification was Cancer diagnosed, but who had no REFERRAL REQUEST for biopsy or a REFERRAL REQUEST for biopsy where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was Inconclusive.
Referred for cytology and/or core biopsy (column 14)
- Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the date of the screen or had no breast assessment final outcome recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
- Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded date biopsy taken (see ACTIVITY DATE) .
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e cancer diagnosed. The breast assessment final outcome classification for these women is Cancer diagnosed.
Table A: 1st Invitation for Routine Screening
Part A1: Invitations and Outcomes
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table A: 1st Invitation for Routine ScreeningTable A: 1st Invitation for Routine Screening
Part A3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the test date offered (seeACTIVITY DATE) of the firstScreening Test Invitationwithin the period of the return.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the test date offered (see ACTIVITY DATE) of the first Screening Test Invitation within the period of the return.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). TheBIOPSY REFERRAL OUTCOMEclassification isPositive; i.e. cancer detected invasive size known.Invasive size (of cancer)<10mm (column 29)Invasive size (of cancer)>=10mm & <15mm (column 30)Invasive size (of cancer)>=15mm & <20mm (column 31)Invasive size (of cancer)>=20mm & <50mm (column 32)Invasive size (of cancer)>=50mm (column 33)Invasive size: Size not known (column 34)These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size not known.
Total invasive (column 35)
This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Part A4: Outcome measuresPart A4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely microinvasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the the appropriate age group).Benign Therapeutic operation: Number (column 40)This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).
Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).
Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group).
Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.
Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.
Part A5: Data Completeness Indicators
Part A5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column) in Part A5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)
Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)
Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)
Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)
Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) multiplied by 100 (for the appropriate age group)
Part A6: Status of cancer
Part A6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part A6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women withBIOPSY REFERRAL OUTCOMEclassification ofPositive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not knownwith a <<a alias="name" href="ref:cc5368fa-21d1-11d9-b461-eb616f776d08"> where aLYMPH NODE STATUShas been recorded.Women with an invasive cancer detected: number positive (column 62)Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.
Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.
Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Requests for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Requests for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Requests for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
KC62 Annex: Adult Screening Programmes - Breast ScreeningKC62 Annex: Adult Screening Programmes - Breast Screening
This is detailed information on each cancer detected for epidemiological comparisons to be made both within the Screening Programme and with data from other sources.
Line for each cancer detected (first column)
A separate line should be used for each PERSON with cancer detected.
Relevant tables (i.e. A, B, C1 etc.) (column 1)
The relevant table that the summary information has been included in for eachPERSONwith cancer detected.Age at first offered appointment in this episode (years) (column 2)The relevant table that the summary information has been included in for each PERSON with cancer detected.
Age at first offered appointment in this episode (years) (column 2)
This is derived from the PERSON BIRTH DATE of the PERSON and is their age at the time of their first test date offered (see APPOINTMENT DATE OFFERED) for women invited as part of a Screening Programme or first test date offered (see APPOINTMENT DATE OFFERED) for women with a REFERRAL REQUEST for Screening Test.
Type of cancer (invasive, non-invasive or micro-invasive) (column 3)
The BIOPSY REFERRAL OUTCOME from the Request for Pathology Investigation of the PERSON.
Invasive is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, invasive size not known or Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive status not known. Non-invasive is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive. Micro-invasive is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, definitely micro-invasive.Size of tumour (mm) (column 4)
The INVASIVE LESION SIZE from the Request for Pathology Investigation of the PERSON.
Grade of tumour (I, II or III for invasive and high or low/intermediate for DCIS) (column 5)
The BIOPSY REFERRAL OUTCOME from the Request for Pathology Investigation of the PERSON.
Grade I is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, invasive size not known, Grade I or Positive; i.e. cancer detected, invasive size known, Grade I. Grade II is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, invasive size not known, Grade II or Positive; i.e. cancer detected, invasive size known, Grade II. Grade III is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, invasive size not known, Grade III or Positive; i.e. cancer detected, invasive size known, Grade III. Low is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected). Intermediate is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected)or Positive; i.e. cancer detected, definitely micro-invasive, intermediate (DCIS only detected). High is BIOPSY REFERRAL OUTCOME of Positive; i.e. cancer detected non-invasive or possibly micro-invasive high (DCIS only detected) or Positive; i.e. cancer detected definitely micro-invasive high (DCIS only detected).Number of lymph nodes sampled (column 6)
The number of Requests for Pathology Investigation for the PERSON with a LYMPH NODE STATUS. Each lymph node sampled will be a different Request for Pathology Investigation. Where their have been no lymph nodes sampled enter zero. If any LYMPH NODE STATUSES are not yet available enter not known.
Number sampled positive (column 7)
The number of Requests for Pathology Investigation for the PERSON with a LYMPH NODE STATUS of lymph node positive.
Number sampled negative (column 8)
The number of Requests for Pathology Investigation for the PERSON with a LYMPH NODE STATUS of lymph node negative.
Histological type (column 9)
The CANCER HISTOLOGICAL TYPE from the Request for Pathology Investigation of the PERSON.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table B: Routine invitation to previous non-attendersThis table reports the persons in aScreening Programmefor Breast Screening whoseSCREENING STATUSisroutine recalland the lastScreening Test Invitationresulted inATTENDED OR DID NOT ATTENDofPatient arrived late and could not be seenorAppointment cancelled by the patientorDid not attend - no advance warning given.Part B1: Invitations and Outcomes- This table reports the persons in a Screening Programme for Breast Screening whose SCREENING STATUS is routine recall and the last Screening Test Invitation resulted in ATTENDED OR DID NOT ATTEND of Patient arrived late and could not be seen or Appointment cancelled by the patient or Did not attend - no advance warning given.
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from the PERSON BIRTH DATE of the PERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.
Lines 13 - 24 in Part B2 Assessment and lines 25 - 36 in Part B3 Cancers diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of Screening Test Invitations where the first Screening Test Invitation has a test date offered (see ACTIVITY DATE) in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL REQUEST for breast assessment was made.
Number screened (technically adequate) (column 3)
Count of women with a Screening Test Date in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid Screening Test Date but where no breast cancer screening test outcome (see BREAST ASSESSMENT OR TEST OUTCOME) has been recorded.
Outcome of initial screen: Routine recall (column 5)
Count of women with a breast cancer screening test outcome classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a breast cancer screening test outcome classification of Early recall but without a REFERRAL REQUEST for breast assessment.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL REQUEST for breast assessment. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL REQUEST for breast assessment who failed to attend for all required assessment appointments and for whom there is no breast assessment final outcome (see BREAST ASSESSMENT OR TEST OUTCOME).
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a breast assessment date (see ACTIVITY DATE) but where no breast assessment final outcome has been recorded.
Final outcome of assessment: Routine recall (column 10)
Count of women with a breast assessment date and a breast assessment final outcome classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a breast assessment date and a breast assessment final outcome classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a breast assessment date and a breast assessment final outcome classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part B2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a breast assessment date whose breast assessment final outcome classification was Cancer diagnosed, but who had no REFERRAL REQUEST for biopsy or a REFERRAL REQUEST for biopsy where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was Inconclusive.
Referred for cytology and/or core biopsy (column 14)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the date of the screen or had no breast assessment final outcome recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded date biopsy taken (see ACTIVITY DATE).
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed. The breast assessment final outcome classification for these women is Cancer diagnosed.
Table B: Routine invitation to previous non-attenders
Part B1: Invitations and Outcomes
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table B: Routine invitation to previous non-attendersTable B: Routine invitation to previous non-attenders
Part B3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the test date offered (seeACTIVITY DATE) of the firstScreening Test Invitationwithin the period of the return.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the test date offered (see ACTIVITY DATE) of the first Screening Test Invitation within the period of the return.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). TheBIOPSY REFERRAL OUTCOMEclassification isPositive; i.e. cancer detected invasive size known.Invasive size (of cancer)<10mm (column 29)Invasive size (of cancer)>=10mm & <15mm (column 30)Invasive size (of cancer)>=15mm & <20mm (column 31)Invasive size (of cancer)>=20mm & <50mm (column 32)Invasive size (of cancer)>=50mm (column 33)Invasive size: Size not known (column 34)These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size not known.
Total invasive (column 35)
- This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table B: Routine invitation to previous non-attendersTable B: Routine invitation to previous non-attenders
Part B4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).
Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).
Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group).
Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.
Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.
Part B5: Data Completeness Indicators
Part B5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column) in Part B5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)
Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)
Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)
Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)
Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) multiplied by 100 (for the appropriate age group)
Part B6: Status of cancer
Part B6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part B6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.
Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.
Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table C1: Routine invitation to previous attenders (Last screen within 5 years)This table reports the person in aScreening Programmefor Breast Screening whoseSCREENING STATUSisroutine recalland the lastScreening Testwas within 5 years.Part C1/1: Invitations and Outcomes- This table reports the person in a Screening Programme for Breast Screening whose SCREENING STATUS is routine recall and the last Screening Test was within 5 years.
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from the PERSON BIRTH DATE of the test date offered (see ACTIVITY DATE). Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population. Line 12 gives the total of all women in lines 01 and 10 regardless of age.
Lines 13 - 24 in Part C1/2 Assessment and lines 25 - 36 in Part C1/2 Cancers diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of Screening Test Invitations where the first Screening Test Invitation has a test date offered in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL REQUEST for breast assessment was made.
Number screened (technically adequate) (column 3)
Count of women with a Screening Test Date in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid Screening Test Date but where no SCREENING TEST RESULT has been recorded.
Outcome of initial screen: Routine recall (column 5)
Count of women with a breast cancer screening test outcome (see BREAST ASSESSMENT OR TEST OUTCOME) classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a breast cancer screening test outcome classification of Early recall but without a REFERRAL REQUEST for breast assessment.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL REQUEST for breast assessment. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL REQUEST for breast assessment who failed to attend for all required assessment appointments and for whom there is no breast assessment final outcome (see BREAST ASSESSMENT OR TEST OUTCOME).
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a breast assessment date (see ACTIVITY DATE) but where no breast assessment final outcome has been recorded
Final outcome of assessment: Routine recall (column 10)
Count of women with a breast assessment date and a breast assessment final outcome classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a breast assessment date and a breast assessment final outcome classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a breast assessment date and a breast assessment final outcome classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part C1/2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a breast assessment date whose breast assessment final outcome classification was Cancer diagnosed, but who had no REFERRAL REQUEST for biopsy or a REFERRAL REQUEST for biopsy where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was Inconclusive.
Referred for cytology and/or core biopsy (column 14)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the date of the screen or had no breast assessment final outcome recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded date biopsy taken (see ACTIVITY DATE).
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed. The breast assessment final outcome classification for these women is Cancer diagnosed.
Table C1: Routine invitation to previous attenders (Last screen within 5 years)
Part C1/1: Invitations and Outcomes
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table C1: Routine invitation to previous attenders (Last screen within 5 years)Table C1: Routine invitation to previous attenders (Last screen within 5 years)
Part C1/3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the test date offered (seeACTIVITY DATE) of the firstScreening Test Invitationwithin the period of the return.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the test date offered (see ACTIVITY DATE) of the first Screening Test Invitation within the period of the return.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). TheBIOPSY REFERRAL OUTCOMEclassification isPositive; i.e. cancer detected Invasive size known.Invasive size (of cancer)<10mm (column 29)Invasive size (of cancer)>=10mm & <15mm (column 30)Invasive size (of cancer)>=15mm & <20mm (column 31)Invasive size (of cancer)>=20mm & <50mm (column 32)Invasive size (of cancer)>=50mm (column 33)Invasive size: Size not known (column 34)These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected Invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size not known.
Total invasive (column 35)
This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table C1: Routine invitation to previous attenders (Last screen within 5 years)Table C1: Routine invitation to previous attenders (Last screen within 5 years)
Part C1/4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).
Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).
Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group).
Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.
Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.
Part C1/5: Data Completeness Indicators
Part C1/5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column) in Part C1/5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)
Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)
Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)
Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)
Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely microinvasive (column 28) multiplied by 100 (for the appropriate age group)
Part C1/6: Status of cancer
Part C1/6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part C1/6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.
Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.
Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table C2: Routine invitation to previous attenders (Last screen more than 5 years)This table reports the person in aScreening Programmefor Breast Screening whoseSCREENING STATUSisroutine recalland the lastScreening Testwas more than 5 years.Part C2/1: Invitations and Outcomes- This table reports the person in a Screening Programme for Breast Screening whose SCREENING STATUS is routine recall and the last Screening Test was more than 5 years.
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS BreastScreening Programmetarget age range of 50 to 70 - theScreening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.This is derived from the PERSON BIRTH DATE of the PERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.
Lines 13 - 24 in Part C2/2 Assessment and lines 25 - 36 in Part C2/2 Cancers diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of Screening Test Invitations where the first Screening Test Invitation has a test date offered (see ACTIVITY DATE) in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL REQUEST for breast assessment was made.
Number screened (technically adequate) (column 3)
Count of women with a Screening Test Date in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid Screening Test Date but where no breast cancer screening test outcome (see BREAST ASSESSMENT OR TEST OUTCOME) has been recorded.
Outcome of initial screen: Routine recall (column 5)
Count of women with a breast cancer screening test outcome classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a breast cancer screening test outcome classification of Early recall but without a REFERRAL REQUEST for breast assessment.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL REQUEST for breast assessment. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL REQUEST for breast assessment who failed to attend for all required assessment appointments and for whom there is no breast assessment final outcome (see BREAST ASSESSMENT OR TEST OUTCOME).
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a breast assessment date (see ACTIVITY DATE) but where no breast assessment final outcome has been recorded.
Final outcome of assessment: Routine recall (column 10)
Count of women with a breast assessment date and a breast assessment final outcome classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a breast assessment date and a breast assessment final outcome classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a breast assessment date and a breast assessment final outcome classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part C2/2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a breast assessment date whose breast assessment final outcome classification was Cancer diagnosed, but who had no REFERRAL REQUEST for biopsy or a REFERRAL REQUEST for biopsy where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was Inconclusive.
Referred for cytology and/or core biopsy (column 14)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the date of the screen or had no breast assessment final outcome recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded date biopsy taken (see ACTIVITY DATE).
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed. The breast assessment final outcome classification for these women is Cancer diagnosed.
Table C2: Routine invitation to previous attenders (Last screen more than 5 years)
Part C2/1: Invitations and Outcomes
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table C2: Routine invitation to previous attenders (Last screen more than 5 years)Table C2: Routine invitation to previous attenders (Last screen more than 5 years)
Part C2/3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the test date offered (seeACTIVITY DATE) of the firstScreening Test Invitationwithin the period of the return.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the test date offered (see ACTIVITY DATE) of the first Screening Test Invitation within the period of the return.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer diagnosed invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer diagnosed non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer diagnosed definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). TheBIOPSY REFERRAL OUTCOMEclassification isPositive; i.e. cancer diagnosed invasive size known.Invasive size (of cancer)<10mm (column 29)Invasive size (of cancer)>=10mm & <15mm (column 30)Invasive size (of cancer)>=15mm & <20mm (column 31)Invasive size (of cancer)>=20mm & <50mm (column 32)Invasive size (of cancer)>=50mm (column 33)Invasive size: Size not known (column 34)These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed invasive size not known.
Total invasive (column 35)
This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table C2: Routine invitation to previous attenders (Last screen more than 5 years)Table C2: Routine invitation to previous attenders (Last screen more than 5 years)
Part C2/4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).
Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).
Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group).
Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.
Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.
Part C2/5: Data Completeness Indicators
Part C2/5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column) in Part C2/5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)
Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)
Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)
Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)
Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) multiplied by 100 (for the appropriate age group)
Part C2/6: Status of cancer
Part C2/6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part C2/6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.
Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.
Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table D: Early RecallsThis table reports thePERSON IN A SCREENING PROGRAMMEfor Breast Screening whoseSCREENING TEST RESULTisNon-routine/early recall advised.Part D1: Invitations and OutcomesTable D: Early Recalls
- This table reports the PERSON IN A SCREENING PROGRAMME for Breast Screening whose SCREENING TEST RESULT is Non-routine/early recall advised.
Part D1: Invitations and Outcomes
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS BreastScreening Programmetarget age range of 50 to 70 - theScreening PopulationLine 12 gives the total of all women in lines 01 to 10 regardless of age.This is derived from the PERSON BIRTH DATE of the PERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population Line 12 gives the total of all women in lines 01 to 10 regardless of age.
Lines 13 - 24 in Part D2 Assessment and lines 25 - 36 in Part D2 Cancers diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of Screening Test Invitation where the first TEST DATE OFFERED in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL FOR BREAST ASSESSMENT was made.
Number screened (technically adequate) (column 3)
Count of women with a SCREENING TEST DATE in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid SCREENING TEST DATE but where no SCREENING TEST RESULT has been recorded.
Outcome of initial screen: Routine recall (column 5)
Count of women with a BREAST CANCER SCREENING TEST OUTCOME classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a BREAST CANCER SCREENING TEST OUTCOME classification of Early recall but without a REFERRAL FOR BREAST ASSESSMENT.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL FOR BREAST ASSESSMENT. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL FOR BREAST ASSESSMENT who failed to attend for all required assessment appointments and for whom there is no BREAST ASSESSMENT FINAL OUTCOME.
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a BREAST ASSESSMENT DATE but where no BREAST ASSESSMENT FINAL OUTCOME has been recorded.
Final outcome of assessment: Routine recall (column 10)
Count of women with a BREAST ASSESSMENT DATE and a BREAST ASSESSMENT FINAL OUTCOME classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a BREAST ASSESSMENT DATE and a BREAST ASSESSMENT FINAL OUTCOME classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a BREAST ASSESSMENT DATE and a BREAST ASSESSMENT FINAL OUTCOME classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part D2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a BREAST ASSESSMENT DATE whose BREAST ASSESSMENT FINAL OUTCOME classification was Cancer diagnosed, but who had no BIOPSY REFERRAL OUTCOME or a REFERRAL FOR BIOPSY where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was Inconclusive.
Referred for cytology and/or core biopsy (column 14)
Count of women with a BREAST CANCER SCREENING TEST OUTCOME classification of Referred for assessment and a subsequent REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a BREAST CANCER SCREENING TEST OUTCOME classification of Referred for assessment and a subsequent REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the date of the screen or had no BREAST ASSESSMENT FINAL OUTCOME recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a BREAST CANCER SCREENING TEST OUTCOME classification of Referred for assessment, a subsequent REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BREAST ASSESSMENT FINAL OUTCOME classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a BREAST CANCER SCREENING TEST OUTCOME classification of Referred for assessment, a subsequent REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BREAST ASSESSMENT FINAL OUTCOME classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a BREAST CANCER SCREENING TEST OUTCOME classification of Referred for assessment, a subsequent REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BREAST ASSESSMENT FINAL OUTCOME classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
Count of women with a REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded DATE BIOPSY TAKEN.
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The BREAST ASSESSMENT FINAL OUTCOME classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The BREAST ASSESSMENT FINAL OUTCOME classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL FOR BIOPSY with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed. The BREAST ASSESSMENT FINAL OUTCOME classification for these women is Cancer diagnosed.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table D3: Early RecallsTable D3: Early Recalls
Part D3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the test date offered (seeACTIVITY DATE) of the firstScreening Test Invitationwithin the period of the return.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the test date offered (see ACTIVITY DATE) of the first Screening Test Invitation within the period of the return.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with aBIOPSY REFERRAL OUTCOMEclassification ofPositive; i.e. cancer detected invasive status not knwon.Non-invasive or possibly micro-invasive (column 27)Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). TheBIOPSY REFERRAL OUTCOMEclassification isPositive; i.e. cancer detected invasive size known.Invasive size (of cancer)<10mm (column 29)Invasive size (of cancer)>=10mm & <15mm (column 30)Invasive size (of cancer)>=15mm & <20mm (column 31)Invasive size (of cancer)>=20mm & <50mm (column 32)Invasive size (of cancer)>=50mm (column 33)Invasive size: Size not known (column 34)These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size not known.
Total invasive (column 35)
This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table D: Early RecallTable D: Early Recall
Part D4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).
Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).
Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group).
Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.
Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.
Part D5: Data Completeness Indicators
Part D5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column) in Part D5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)
Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)
Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)
Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)
Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) multiplied by 100 (for the appropriate age group)
Part D6: Status of cancer
Part D6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part D6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.
Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.
Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table E: Self/GP referrals of women not screened previouslyThis table reports women with aREFERRAL REQUESTforScreening TestwithSCREENING REFERRAL SOURCEofSelf-referralorGMPwith no previousScreening Test.These women have been referred directly for aScreening Testrather than as an invitation as part of aScreening Programme.Part E1: Invitations and Outcomes- This table reports women with a REFERRAL REQUEST for Screening Test with SCREENING REFERRAL SOURCE of Self-referral or GMP with no previous Screening Test. These women have been referred directly for a Screening Test rather than as an invitation as part of a Screening Programme.
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS BreastScreening Programmetarget age range of 50 to 70 - theScreening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.This is derived from the PERSON BIRTH DATE of the PERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.
Lines 13 - 24 in Part E2 Assessment and lines 25 - 36 in Part E2 Cancers diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of REFERRAL REQUESTS for Screening Test where the first test date offered (see ACTIVITY DATE) is in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL REQUEST for breast assessment was made.
Number screened (technically adequate) (column 3)
Count of women with a Screening Test Date in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid Screening Test Date but where no breast cancer screening test outcome (see BREAST ASSESSMENT OR TEST OUTCOME) has been recorded.
Outcome of initial screen: Routine recall (column 5)
Count of women with a breast cancer screening test outcome classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a breast cancer screening test outcome classification of Early recall but without a REFERRAL REQUEST for breast assessment.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL REQUEST for breast assessment. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL REQUEST for breast assessment who failed to attend for all required assessment appointments and for whom there is no breast assessment final outcome (see BREAST ASSESSMENT OR TEST OUTCOME).
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a breast assessment date (see ACTIVITY DATE) but where no breast assessment final outcome has been recorded.
Final outcome of assessment: Routine recall (column 10)
Count of women with a breast assessment date and a breast assessment final outcome classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a breast assessment date and a breast assessment final outcome classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a breast assessment date and a breast assessment final outcome classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part E2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a breast assessment date whose breast assessment final outcome classification was Cancer diagnosed, but who had no REFERRAL REQUEST for biopsy or a REFERRAL REQUEST for biopsy where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was inconclusive.
Referred for cytology and/or core biopsy (column 14)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the date of the screen or had no breast assessment final outcome recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded date biopsy taken (see ACTIVITY DATE).
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed. The breast assessment final outcome classification for these women is Cancer diagnosed.
Table E: Self/GP referrals of women not screened previously
Part E1: Invitations and Outcomes
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table E: Self/GP referrals of women not screened previouslyTable E: Self/GP referrals of women not screened previously
Part E3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the first test date offered (seeACTIVITY DATE) following aREFERRAL REQUESTforScreening Test.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the first test date offered (see ACTIVITY DATE) following a REFERRAL REQUEST for Screening Test.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). TheBIOPSY REFERRAL OUTCOMEclassification isPositive; i.e. cancer detected Invasive size known.Invasive size (of cancer)<10mm (column 29)Invasive size (of cancer)>=10mm & <15mm (column 30)Invasive size (of cancer)>=15mm & <20mm (column 31)Invasive size (of cancer)>=20mm & <50mm (column 32)Invasive size (of cancer)>=50mm (column 33)Invasive size: Size not known (column 34)These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected Invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected Invasive size not known.
Total invasive (column 35)
This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table E: Self/GP referrals of women not screened previouslyTable E: Self/GP referrals of women not screened previously
Part E4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).
Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).
Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).
Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).
Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group). Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.
Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.
Part E5: Data Completeness Indicators
Part E5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.
Age Groups of women (first column) in Part E5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)
Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)
Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)
Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)
Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)
Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) multiplied by 100 (for the appropriate age group)
Part E6: Status of cancer
Part E6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part E6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.
Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.
Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table F1: Self/GP referrals of women screened previously (Last screen within 5 years)This table reports women with aREFERRAL REQUESTforScreening TestwithSCREENING REFERRAL SOURCEofSelf-referralorGMPwith a previousScreening Testwithin the last 5 years.These women have been referred directly for aScreening Testrather than as an invitation as part of aScreening Programme.Part F1/1: Invitations and Outcomes- This table reports women with a REFERRAL REQUEST for Screening Test with SCREENING REFERRAL SOURCE of Self-referral or GMP with a previous Screening Test within the last 5 years. These women have been referred directly for a Screening Test rather than as an invitation as part of a Screening Programme.
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - theScreening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.This is derived from the PERSON BIRTH DATE of the PERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.
Lines 13 - 24 in Part F1/2 Assessment and lines 25 - 36 in Part F1/2 Cancers diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of REFERRAL REQUESTS for Screening Test where the first test date offered (see ACTIVITY DATE) is in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL REQUEST for breast assessment was made.
Number screened (technically adequate) (column 3)
Count of women with a Screening Test Date in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid Screening Test Date but where no breast cancer screening test outcome (see BREAST ASSESSMENT OR TEST OUTCOME) has been recorded.
Outcome of initial screen: Routine recall (column 5)
Count of women with a breast cancer screening test outcome classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a breast cancer screening test outcome classification of Early recall but without a REFERRAL REQUEST for breast assessment.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL REQUEST for breast assessment. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL REQUEST for breast assessment who failed to attend for all required assessment appointments and for whom there is no breast assessment final outcome (see BREAST ASSESSMENT OR TEST OUTCOME).
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a breast assessment date (see ACTIVITY DATE) but where no breast assessment final outcome has been recorded.
Final outcome of assessment: Routine recall (column 10)
Count of women with a breast assessment date and a breast assessment final outcome classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a breast assessment date and a breast assessment final outcome classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a breast assessment date and a breast assessment final outcome classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part F1/2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a breast assessment date whose breast assessment final outcome classification was Cancer diagnosed, but who had no REFERRAL REQUEST for biopsy or a REFERRAL REQUEST for biopsy where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was Inconclusive.
Referred for cytology and/or core biopsy (column 14)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the date of the screen or had no breast assessment final outcome recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a referral for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded date biopsy taken (.
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed. The breast assessment final outcome classification for these women is Cancer diagnosed.
Table F1: Self/GP referrals of women screened previously (Last screen within 5 years)
Part F1/1: Invitations and Outcomes
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table F1: Self/GP referrals of women screened previously (Last screen within 5 years)Table F1: Self/GP referrals of women screened previously (Last screen within 5 years)
Part F1/3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the first test offered (seeACTIVITY DATE) following aREFERRAL REQUESTforScreening Test.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the first test offered (see ACTIVITY DATE) following a REFERRAL REQUEST for Screening Test.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected invasive size not known.
Total invasive (column 35)
This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table F1: Self/GP referrals of women screened previously (Last screen within 5 years)Table F1: Self/GP referrals of women screened previously (Last screen within 5 years)
Part F1/4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group).
Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.Part F1/5: Data Completeness Indicators
Part F1/5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.Age Groups of women (first column) in Part F1/5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) multiplied by 100 (for the appropriate age group)Part F1/6: Status of cancer
Part F1/6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part F1/6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table F2: Self/GP referrals of women screened previously (Last screen more than 5 years)This table reports women with aREFERRAL REQUESTforScreening TestwithSCREENING REFERRAL SOURCEofSelf-referralorGMPwith a previousScreening Testmore than 5 years previously.These women have been referred directly for aScreening Testrather than as an invitation as part of aScreening Programme.Part F2/1: Invitations and Outcomes- This table reports women with a REFERRAL REQUEST for Screening Test with SCREENING REFERRAL SOURCE of Self-referral or GMP with a previous Screening Test more than 5 years previously. These women have been referred directly for a Screening Test rather than as an invitation as part of a Screening Programme.
This is a summary of the outcomes of screening and assessment of all women invited and/or screened.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - theScreening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.This is derived from the PERSON BIRTH DATE of the PERSON. Line 01 includes all women who were aged 44 or less at the time of the date of their first offered appointment for screening in the period covered by the return. Lines 02 to 09 include women in specified age groups. Line 10 includes all women who were aged 75 or over. Line 11 gives the total of all women in lines 03 to 08, giving a summary of the women in the NHS Breast Screening Programme target age range of 50 to 70 - the Screening Population. Line 12 gives the total of all women in lines 01 to 10 regardless of age.
Lines 13 - 24 in Part F2/2 Assessment and lines 25 - 36 in Part F2/2 Cancers diagnosed follow the pattern described above.
Number of women invited (column 1)
Count of REFERRAL REQUESTS for Screening Test where the first offered date (see ACTIVITY DATE) is in the period covered by the return.
Lost to follow-up after technically inadequate screening mammogram (column 2)
Count of women whose SCREENING TEST RESULT classification was Inadequate test, and for whom no REFERRAL REQUEST for breast assessment was made.
Number screened (technically adequate) (column 3)
Count of women with a Screening Test Date in the period covered by the return whose SCREENING TEST RESULT classification was not Inadequate test.
Outcome of initial screen : Not known (column 4)
Count of women with a valid Screening Test Date but where no breast cancer screening test outcome (see BREAST ASSESSMENT OR TEST OUTCOME) has been recorded.
Outcome of initial screen: Routine recall (column 5)
Count of women with a breast cancer screening test outcome classification of Routine recall.
Outcome of initial screen: Early recall (column 6)
Count of women with a breast cancer screening test outcome classification of Early recall but without a REFERRAL REQUEST for breast assessment.
Outcome of initial screen: Referred for assessment (column 7)
Count of women with a REFERRAL REQUEST for breast assessment. This covers all the women reported in columns 8 to 12.
Final outcome of assessment: Failed to attend for assessment (column 8)
Count of women with a REFERRAL REQUEST for breast assessment who failed to attend for all required assessment appointments and for whom there is no breast assessment final outcome (see BREAST ASSESSMENT OR TEST OUTCOME).
Final outcome of assessment: Outcome of assessment not known (column 9)
Count of women with a breast cancer screening test outcome but where no breast assessment final outcome has been recorded.
Final outcome of assessment: Routine recall (column 10)
Count of women with a breast assessment date (see ACTIVITY DATE) and a breast assessment final outcome classification of Routine recall.
Final outcome of assessment: Early recall (column 11)
Count of women with a breast assessment date and a breast assessment final outcome classification of Early recall.
Final outcome of assessment: Cancer (column 12)
Count of women with a breast assessment date and a breast assessment final outcome classification of Cancer diagnosed. The total recorded in this column will equal the total recorded in columns 13, 18 and 24.
Part F2/2: Assessment
This part breaks down the outcomes of assessment by the procedures involved for all women assessed as a result of screening.
Cancer diagnosed without cytology or histology (column 13)
Count of women with a breast assessment date whose breast assessment final outcome classification was Cancer diagnosed, but who had no REFERRAL REQUEST for biopsy or a REFERRAL REQUEST for biopsy where the PATHOLOGY INVESTIGATION TYPE CODE classification was not Cytology and the BIOPSY REFERRAL OUTCOME classification was Inconclusive.
Referred for cytology and/or core biopsy (column 14)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy.
Not referred for open biopsy: No result recorded/inadequate result (column 15)
Count of women with a breast cancer screening test outcome classification of Referred for assessment and a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women did not complete any or all procedures within 6 months of the DATE of the screen or had no result recorded.
Not referred for open biopsy: Routine recall (column 16)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Routine recall.
Not referred for open biopsy: Early recall (column 17)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Early recall.
Not referred for open biopsy: Cancer (column 18)
Count of women with a breast cancer screening test outcome classification of Referred for assessment, a subsequent REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy but without any PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy). These women have a breast assessment final outcome classification of Cancer diagnosed.
Referred for open biopsy (column 19)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Cytology or Core biopsy followed by a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE CODE classification of Histology (open biopsy).
Total referred for open biopsy (column 20)
Total count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE classification of Histology (open biopsy).
Up to and including open biopsy: No result/inadequate result (column 21)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE classification of Histology (open biopsy). These women have a BIOPSY REFERRAL OUTCOME classification of Inconclusive or Biopsy not done or result not yet known or did not attend for the biopsy within 6 months of the date of the Screening Test having no recorded date biopsy taken (see ACTIVITY DATE).
Up to and including open biopsy: Result: Benign/normal: Routine recall (column 22)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Routine recall.
Up to and including open biopsy: Result: Benign/normal: Early recall (column 23)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Benign or negative. The breast assessment final outcome classification for these women is Early recall.
Up to and including open biopsy: Cancer (column 24)
Count of women with a REFERRAL REQUEST for biopsy with a PATHOLOGY INVESTIGATION TYPE classification of Histology (open biopsy). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed. The breast assessment final outcome classification for these women is Cancer diagnosed.
Table F2: Self/GP referrals of women screened previously (Last screen more than 5 years)
Part F2/1: Invitations and Outcomes
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table F2: Self/GP referrals of women screened previously (Last screen more than 5 years)Table F2: Self/GP referrals of women screened previously (Last screen more than 5 years)
Part F2/3: Cancers Diagnosed
This part of the return describes the cancers formally diagnosed in women assessed as a result of screening. Only breast cancers should be reported, as defined in the Information and Training Manual for England and Wales.
Age at first offered appointment (first column)
This is derived from theBIRTH DATEof thePERSONand the first test date offered (seeACTIVITY DATE) following aREFERRAL REQUESTforScreening Test.Total number of women with cancer (column 25)This is derived from the PERSON BIRTH DATE of the PERSON and the first test date offered (see ACTIVITY DATE) following a REFERRAL REQUEST for Screening Test.
Total number of women with cancer (column 25)
Count of all women in columns 18 and 24 of Part 2 Assessment i.e. those women with a proven diagnosis of breast cancer.
Invasive status not known (column 26)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer diagnosed invasive status not known.
Non-invasive or possibly micro-invasive (column 27)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer diagnosed non-invasive or possibly micro-invasive.
Definitely micro-invasive (column 28)
Count of women included in Part 3 with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer diagnosed definitely micro-invasive.
Invasive size (columns 29 - 33)
These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). TheBIOPSY REFERRAL OUTCOMEclassification isPositive; i.e. cancer diagnosed invasive size known.Invasive size (of cancer)<10mm (column 29)Invasive size (of cancer)>=10mm & <15mm (column 30)Invasive size (of cancer)>=15mm & <20mm (column 31)Invasive size (of cancer)>=20mm & <50mm (column 32)Invasive size (of cancer)>=50mm (column 33)Invasive size: Size not known (column 34)These columns count all cancers classified as invasive, separated according to the pathological size of the cancer (INVASIVE LESION SIZE). The BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed invasive size known.
Invasive size (of cancer) <10mm (column 29) Invasive size (of cancer) >=10mm & <15mm (column 30) Invasive size (of cancer) >=15mm & <20mm (column 31) Invasive size (of cancer) >=20mm & <50mm (column 32) Invasive size (of cancer) >=50mm (column 33) Invasive size: Size not known (column 34)
This column counts invasive cancers where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer diagnosed invasive size not known.
Total invasive (column 35)
This column counts the total number of cancers classified as invasive, that is with a BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected invasive size known or Positive; i.e. cancer detected invasive size not known.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table F2: Self/GP referrals of women not screened previouslyTable F2: Self/GP referrals of women not screened previously
Part F2/4: Outcome measures
Part 4 presents a selection of outcome measures related to NHS Breast Screening Programme (NHSBSP) quality targets.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.Age Groups of women (first column)
Outcome measures are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 37)
These are the outcome measures for women in the age group 50-64
Age Group (50-70) (line 38)
These are the outcome measures for women in the age group 50-70
Total all ages (line 39)
These are the outcome measures for women of all ages.
Uptake rate (% of invited) (column 36)
This column gives the uptake rate (also known as the acceptance rate) for screening. It is defined as the percentage of women who receive a technically adequate and complete screen as a result of an invitation for routine screening, and is calculated as:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).Referral rate (% of screened) (column 37)
This column gives the rate of referrals to assessment from screening. It is defined as the percentage of women screened who are referred for any assessment procedure and is calculated as:
Outcome of initial screen: Referred for assessment (column 7) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Non-invasive or micro-invasive cancers (per 1,000 screened) (column 38)
This column gives the cancers detected which are non-invasive, possibly micro-invasive, or definitely micro-invasive, per 1,000 screened calculated as:
Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Benign biopsy rate (per 1,000 screened) (column 39)
This column gives the women screened who have an open biopsy with a result of benign or normal per 1,000 screened, calculated as:
Up to and including open biopsy: Result: benign/normal (columns 22 + 23) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Benign Therapeutic operation: Number (column 40)
This column gives the number of women screened who had a REFERRAL REQUEST for breast treatment and who had a BENIGN THERAPEUTIC OPERATION by the appropriate age group.
Benign Therapeutic operation: Rate (per 1,000 screened) (column 41)
This column gives the women screened who have a BENIGN THERAPEUTIC OPERATION per 1,000 screened, calculated as:
Number of BENIGN THERAPEUTIC OPERATIONS for the period (column 40) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Invasive cancer detection rate (per 1,000 screened) (column 42)
This column gives the rate of invasive cancers detected per 1,000 women screened, calculated as:
Total invasive (column 35) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Detection rate of invasive cancers <10 mm (per 1,000 screened) (column 43)
This column gives the rate of invasive cancers smaller than 10mm detected per 1,000 women screened, calculated as:
Invasive size < 10mm (column 29) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Detection rate of invasive cancers <15 mm (per 1,000 screened) (column 44)
This column gives the rate of invasive cancers smaller than 15mm detected per 1,000 women screened, calculated as:
Invasive size < 15mm (columns 29 + 30) divided by Number screened (technically adequate) (column 3) multiplied by 1000 (for the appropriate age group).Referral rate for cytology and/or core biopsy (% of screened) (column 45)
This column gives the percentage of women screened who are referred for fine needle aspiration cytology and/or core biopsy as part of the assessment process, calculated as:
Referred for cytology and/or core biopsy (column 14) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Referral rate for open biopsy (% of screened) (column 46)
This column gives the percentage of women screened who are referred for an open biopsy, either directly from screening or following other assessment procedures, calculated as:
Total open biopsy (column 20) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Pre-operative diagnosis rate (% of cancers diagnosed) (column 47)
This column gives the percentage of cancers diagnosed cytologically or histologically without surgery, calculated as:
Not referred for open biopsy Cancer (column 18) divided by (Not referred for open biopsy Cancer (column 18) plus Open biopsy: Cancer (column 24)) multiplied by 100 (for the appropriate age group).Early recall rate following assessment (% of screened) (column 48)
This column gives the percentage of women screened who are recommended for early recall following any assessment procedure, calculated as:
Early recall (column 11) divided by Number screened (technically adequate) (column 3) multiplied by 100 (for the appropriate age group).Number of invasive cancers observed (column 49)
This column gives the total number of detected cancers classified as invasive, calculated as:
Total invasive (column 35) (for the appropriate age group).Number of invasive cancers expected (column 50)
This column is derived from the Number of invasive cancers observed (column 49) and a predefined incidence rate (calculated every three years for the appropriate age group).
Please note KC62 is issued as an electronic spreadsheet and the predefined incident rate is contained within the spreadsheet for use within this calculation.Standardised Detection Ratio (SDR) (column 51)
This column is derived from column 49 and column 50.
Please note KC62 is issued as an electronic spreadsheet and the formula to calculate this ratio is contained within the spreadsheet.Part F2/5: Data Completeness Indicators
Part F2/5 gives an indication of the completeness of data recorded on information systems in a variety of key areas.
Please note that where a column number is given within an outcome calculation, it relates to a specified column within the KC62 form for example:
Number screened (technically adequate) (column 3) divided by Number of women invited (column 1) multiplied by 100 (for the appropriate age group).
In this example (column 3) relates to Part 1 Invitations and Outcomes column 3.Age Groups of women (first column) in Part F2/5.
Data Completeness Indicators are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 40)
These are the outcome measures for women in the previous target age group 50-64.
Age Group (50-70) (line 41)
These are the outcome measures for women in the current target age group 50-70.
Total all ages (line 42)
These are the outcome measures for all women reported, regardless of age.
Assessment result not known (% of referred) (column 52)
This column gives the percentage of women assessed for whom the final outcome of assessment is not recorded, calculated as:
Outcome of assessment not known (column 9) divided by Referred for assessment (column 7) minus Failed to attend for assessment (column 8) multiplied by 100 (for the appropriate age group)Cytology and/or core biopsy result not known (% of referred) (column 53)
This column gives the percentage of women referred for one or more cytology and/or core biopsy procedures, for whom a definitive result is not recorded and an open biopsy is not indicated. The column is calculated as:
No result recorded/inadequate result (column 15) divided by Referred for cytology and/or core biopsy (column 14) multiplied by 100 (for the appropriate age group)Open-biopsy result not known (% of referred) (column 54)
This column gives the percentage of women referred for an open biopsy for whom a definitive result is not recorded, calculated as:
No result /inadequate result (column 21) divided by Total open biopsy (column 20) multiplied by 100 (for the appropriate age group)Invasive status of cancer not known (% of all cancers diagnosed) (column 55)
This column gives the percentage of cancers diagnosed by cytology or histology in which the invasive status is not recorded. The column is calculated as:
Invasive status not known (column 26) divided by Total number of women with cancer (column 25) multiplied by 100 (for the appropriate age group)Size not known (% of invasive cancers) (column 56)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but have no size recorded. The column is calculated as:
Size not known (column 34) divided by total number of women with invasive cancer Total invasive (column 35) multiplied by 100 (for the appropriate age group)Lymph node status not known (% of invasive cancers) (column 57)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the lymph node status is unknown. The column is calculated as:
The number of women where no LYMPH NODE STATUS has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)Grade not known (% of invasive cancers) (column 58)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as invasive, but the cancer grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, invasive size not known, grade not known or Positive; i.e. cancer detected, invasive size known, grade not known divided by total number of women with invasive cancer: Total invasive (column 35) multiplied by 100 (for the appropriate age group)Special type not known (% of invasive cancers) (column 59)
This column gives the percentage of cancers diagnosed by cytology or histology which are recorded as invasive, but the special type is not known. The column is calculated as:
The number of women where no INVASIVE CANCER SPECIAL TYPE INDICATOR has been recorded and where the BIOPSY REFERRAL OUTCOME classification is Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known divided by Total invasive (column 35) multiplied by 100 (for the appropriate age group)Grade not known (% of DCIS) (column 60)
This column gives the percentage of cancers diagnosed by cytology or histology, which are recorded as ductal carcinoma in-situ (DCIS), but the grade is not known. The column is calculated as:
The number of women where the BIOPSY REFERRAL OUTCOME is Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, grade not known (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, grade not known (DCIS only detected) divided by total number of women with Non-invasive or possibly micro-invasive (column 27) plus Definitely micro-invasive (column 28) multiplied by 100 (for the appropriate age group)Part F2/6: Status of cancer
Part F2/6 gives status and grades of cancers detected.
Age Groups of women (first column) in Part F2/6.
The status of cancers are assessed within three groups: the first being those within the previous target age range of 50-64, the second within the current target age range of 50-70 and the third, the total of those reported, regardless of age.
Age Group (50-64) (line 43)
This is the outcome measure for women in the previous target age group 50-64
Age Group (50-70) (line 44)
This is the outcome measure for women in the current target age group 50-70
Total all ages (line 45)
This is the outcome measure for all women reported, regardless of age.
Women with an invasive cancer detected: number with lymph nodes sampled (column 61)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number positive (column 62)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known where at least one Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node positive has been recorded.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman and any one of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62, but should not be included in column 63.Women with an invasive cancer detected: number negative (column 63)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a LYMPH NODE STATUS of lymph node negative.
Note where more than one Request for Pathology Investigation with a LYMPH NODE STATUS has been recorded for a woman, then every LYMPH NODE STATUS should be lymph node negative for inclusion in count for column 63. If any of the LYMPH NODE STATUSES is lymph node positive, then the woman should be included in column 62 and not included in column 63.Women with an invasive cancer detected: number with 4 or more nodes assessed (column 64)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected invasive size not known with four or more Request for Pathology Investigation where a LYMPH NODE STATUS has been recorded.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number positive (column 65)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node positive.
Women with an invasive cancer detected: number with 4 or more nodes sampled: number negative (column 66)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with four or more Request for Pathology Investigation with a LYMPH NODE STATUS, any one of which is lymph node negative.
Women with an invasive cancer detected: number grade 1 (column 67)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade I or Positive; i.e. cancer detected, invasive size not known, Grade I.
Women with an invasive cancer detected: number grade 2 (column 68)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known ,Grade II or Positive; i.e. cancer detected, invasive size not known, Grade II.
Women with an invasive cancer detected: number grade 3 (column 69)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known, Grade III or Positive; i.e. cancer detected, invasive size not known, Grade III.
Women with an invasive cancer detected: number special type (column 70)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of special type.
Women with an invasive cancer detected: number not special type (column 71)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, invasive size known or Positive; i.e. cancer detected, invasive size not known with a Request for Pathology Investigation with a INVASIVE CANCER SPECIAL TYPE INDICATOR of not special type.
Women with DCIS only detected: number low or intermediate grade (column 72)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive low (DCIS only detected) or Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, intermediate (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, low (DCIS only detected) or Positive; i.e. cancer detected, definitely microinvasive, intermediate (DCIS only detected).
Women with DCIS only detected: number high grade (column 73)
Count of women with BIOPSY REFERRAL OUTCOME classification of Positive; i.e. cancer detected, non-invasive or possibly micro-invasive, high (DCIS only detected) or Positive; i.e. cancer detected, definitely micro-invasive, high (DCIS only detected).
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table T: All invitations and screenings: Sum of Tables A - F2Table T: All invitations and screenings: Sum of Tables A - F2
Part T1: Invitations and Outcomes and Part T2: Assessment
The totals of the outcomes of screening and assessment of all women invited and/or screened, the totals are summed from:
The Table T headings, lines and columns correspond exactly with the individual content of Tables A to F2 being summed.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table T: All invitations and screenings: Sum of Tables A - F2Table T: All invitations and screenings: Sum of Tables A - F2
Part T3: Cancers Diagnosed
The totals of the cancers formally diagnosed in women assessed as a result of screening. The totals are summed from:
The Table T headings, lines and columns correspond exactly with the individual content of Tables A to F2 being summed.
Change to Central Return Form: Changed Description
KC62: Adult Screening Programmes - Breast Screening
Table T: All invitations and screenings: Sum of Tables A - F2Table T: All invitations and screenings: Sum of Tables A - F2
Part T4: Outcome Measures, Part T5: Data Completeness Indicators and Part T6: Status of Cancer
The totals of outcome measures, data completeness and status of diagnosed cancer. The totals are summed from:
KC62 Table A: Part A4, A5 & A6 First invitation for routine screening KC62 Table B: Part B4, B5 & B6 Routine invitation to previous non-attenders KC62 Table C1: Part C1/4, C1/5 & C1/6 Routine invitation to previous attenders (Last screen within 5 years) KC62 Table C2: Part C2/4, C2/5 & C2/6 Routine invitation to previous attenders (Last screen more than 5 years) KC62 Table D: Part D4, D5 & D6 Early Recalls KC62 Table E: Part E4, E5 & E6 Self/GP referrals of women not screened previously KC62 Table F1: Part F1/4, F1/5 & F1/6 Self/GP referrals of women screened previously (Last screen within 5 years) KC62 Table F2: Part F2/4, F2/5 & F2/6 Self/GP referrals of women screened previously (Last screen more than 5 years previously) The Table T headings, lines and columns correspond exactly with the individual content of Tables A to F2 being summed.
Change to Supporting Information: Changed Description
|
The NHS Data Model and Dictionary is maintained by the NHS Data Model and Dictionary Service. NHS Data Model and Dictionary Service Products The NHS Data Model and Dictionary Service produce other supporting products and services which complement the content of the NHS Data Model and Dictionary. These can be found on the NHS Data Model and Dictionary Service website and can be accessed by clicking on the link to the 'NHS Data Model and Dictionary Service' on the front page of the dictionary. The NHS Data Model and Dictionary Service website contains information, such as: What would you like to do next?
|
Change to Supporting Information: Changed Description
The Glossary lists commonly used terms in alphabetical order. These terms are not defined and therefore do not have a class or attribute. Each entry in the Glossary is shown with its related class and attribute where appropriate.
For example 'Booked Admission' is shown as relating to the class ELECTIVE ADMISSION LIST ENTRY. ELECTIVE ADMISSION LIST ENTRY has an attribute ELECTIVE ADMISSION TYPE and reference to the attribute definition will identify that 'Booked Admission' is one of the national code classifications of ELECTIVE ADMISSION TYPES.
Change to Supporting Information: Changed Description
NHS DATA MODEL AND DICTIONARY
Version 3
What's New: September 2012What's New: November 2012
![]() | Welcome to the NHS Data Model and Dictionary for England If you would like to know more about us or need help using the NHS Data Model and Dictionary, see the Help pages The NHS Data Model and Dictionary provides a reference point for assured information standards to support health care activities within the NHS in England. It has been developed for everyone who is actively involved in the collection of data and the management of information in the NHS. The NHS Data Model and Dictionary is maintained and published by the NHS Data Model and Dictionary Service and all changes are assured by the Information Standards Board for Health and Social Care. Changes are published as Information Standards Notices (ISN) by the Information Standards Board for Health and Social Care and Data Dictionary Change Notices (DDCN) by the NHS Data Model and Dictionary Service. |
| |
Related Links |
Change to Supporting Information: Changed Description
Same Sex Accommodation is where male and female PATIENTS sleep in separate areas and have access to toilets and washing facilities used only by their own SEX.Same Sex Accommodation is where male and female PATIENTS sleep in separate areas and have access to toilets and washing facilities used only by their own sex.
Same Sex Accommodation can be provided in single-sex and mixed-sex WARDS.
In a same-sex WARD, the WARD is occupied by either men or women and has its own dedicated toilet and washing facilities.
In mixed-sex WARDS, Same Sex Accommodation can be provided either as:
- single rooms with same-sex toilet and washing facilities and
- Multi-Bed Bays or rooms occupied solely by either men or women with their own same-sex toilet and washing facilities.
Additionally, PATIENTS should not need to pass through mixed communal areas or sleeping areas, toilet or washing facilities used by the opposite gender in order to get to their own facilities.
Change to Supporting Information: Changed Description
A. Removal of name and address where the NHS Number is present
From 1 April 1999, PATIENT NAME and PATIENT USUAL ADDRESS (not POSTCODE OF USUAL ADDRESS) must be removed from all Commissioning Data Sets where a valid NHS NUMBER is present. This applies to all nationally defined Commissioning Data Set data and any additional locally agreed flows from service providers to commissioning bodies.
A valid NHS NUMBER is one that has passed the check digit calculation on entry into the source system. If an NHS NUMBER is not valid (i.e. does not conform with the check digit algorithm) then PATIENT NAMES and PATIENT USUAL ADDRESSES should not be removed, as the reliability of the NHS NUMBER will not be known.
The NHS NUMBER STATUS INDICATOR CODE is a mandatory part of the Commissioning Data Set. PATIENT NAME and PATIENT USUAL ADDRESS should be removed when a valid NHS NUMBER is present, even if the NHS NUMBER STATUS INDICATOR CODE does not have a status of 01, Number present and verified.
B. Marital Status
Following the recommendations of the Data Protection Registrar, Providers should not record MARITAL STATUS in any CDS TYPE, except in respect of the psychiatric specialities in the Admitted Patient Care CDS Types, where it will continue to be recorded.
C. Sensitive data
The Human Fertilisation and Embryology Act 1990 as amended by the Human Fertilisation and Embryology (Disclosure of Information) Act 1992 imposes statutory restrictions on the disclosure of information about identifiable individuals in connection with certain infertility treatments. A list of the relevant codes is given in Table 1. In these cases the NHS NUMBER, LOCAL PATIENT IDENTIFIER, PATIENT NAMES, POSTCODE OF USUAL ADDRESS and PERSON BIRTH DATE should be omitted from the CDS Types.
From Commissioning Data Set Version 6-2, records where the patient-identifiable data has been withheld should be submitted using the PATIENT IDENTITY - WITHHELD IDENTITY STRUCTURE data group in CDS types where identification is carried. This data group allows only the NHS NUMBER STATUS INDICATOR CODE (the actual value held on source systems should be used), ORGANISATION CODE (RESIDENCE RESPONSIBILITY) and WITHHELD IDENTITY REASON to flow. The WITHHELD IDENTITY REASON allows Health Care Providers to inform their Commissioners why a record has been anonymised. Note that the same rules apply to the additional PATIENT IDENTITY structures relating to Mother and Baby in the Delivery and Birth CDS types.
Other statutory restrictions on the disclosure of PATIENT information do not prohibit the disclosure to individuals involved with the treatment and prevention of certain specific diseases (HIV/AIDS and venereal diseases) in the population.
TABLE 1: TREATMENTS PROVIDED UNDER THE LICENCE OF THE HUMAN FERTILISATION AND EMBRYOLOGY AUTHORITY
Description OPCS-4* ICD-10 Standard In Vitro Fertilisation (IVF) Q13.-1 Introduction of gamete into uterine cavity, or
Q38.3 Endoscopic intrafallopian transfer of gameteZ31.2 In vitro fertilization In Vitro Fertilisation (IVF) with donor sperm Q13.- 1 Introduction of gamete into uterine cavity, or
Q38.3 Endoscopic intrafallopian transfer of gameteZ31.2 In vitro fertilization In Vitro Fertilisation (IVF) with donor eggs Q13.-1 Introduction of gamete into uterine cavity, or
Q38.3 Endoscopic intrafallopian transfer of gameteZ31.2 In vitro fertilization Donor insemination (DI) Q13.3 Intrauterine artificial insemination, or
Q13.2 Intracervical artificial inseminationZ31.1 Artificial insemination Gamete intrafallopian transfer (GIFT) with donor sperm Q38.3 Endoscopic intrafallopian transfer of gamete Z31.3 Other assisted fertilization methods Gamete intrafallopian transfer (GIFT) with donor eggs Q38.3 Endoscopic intrafallopian transfer of gamete Z31.3Other assisted fertilization methods Intracytoplasmic sperm injection (ICSI) Sub-zonal insemination (SUZI) Zygote intrafallopian transfer (ZIFT) Q38.3 Endoscopic intrafallopian transfer of gamete Z31.2 In vitro fertilization Partial Zona Dissection (PZD) Zona drilling Hamster- egg penetration test Assisted hatching Pre-implantation Genetic Diagnosis (PGD) Storage of sperm Storage of embryos Use and storage of testicular tissue Transport/satellite In Vitro Fertilisation (IVF) / Intracytoplasmic sperm injection (ICSI) Embryo donation Z31.8 Other procreative management Research 1.- means all fourth characters of this rubric should be included.
* see OPCS Classification of Interventions and ProceduresAll records containing patient identifiable information, other than those covered by the Human Fertilisation & Embryology Acts, as outlined in the Table above, should be treated as sensitive. ORGANISATIONS may continue to exchange records containing NHS NUMBER, POSTCODE OF USUAL ADDRESS and PERSON BIRTH DATE in these cases, but receiving organisations must ensure that only those staff with legitimate need have access to this information, e.g. public health departments, and strictly on a need to know basis. No-one should have unrestricted access unless fully justified in accordance with the principles of the Caldicott Committee Report.
Where PATIENT level data is required for other purposes within an organisation, it should be anonymised/aggregated prior to disclosure by someone with legitimate access. If this is not practicable, local protocols defining which CDS TYPES are particularly sensitive (including, but not necessarily restricted to HIV/AIDS and venereal disease) agreed by the organisation Caldicott Guardian, should be put in place and identifiers stripped from these records.
Your Caldicott Guardian will be able to advise you further on all issues relating to patient confidentiality.
Where appropriate, further information about confidentiality is contained within the notes for individual data items.
Change to Supporting Information: Changed Description
- Coding and Classifications
- Administrative Codes
- Clinical Coding
- Main Specialty And Treatment Function Codes Table
- ODS Default Codes
- Organisations and NHS Policies
- Mental Health Act Table
- NHS Postcode Directory
- NHS Trust Mergers
- Organisations
- NHS Policies
- NHS Data Model and Dictionary Information
- About Version 3
Change Request Log- Change Request Log
- Disclaimer
- Glossary of Terms
- Meta Model
- Metadata Files
- Contacts/ Links
- Contact Details
- Information Standards Notices (ISNs)
- NHS Data Model and Dictionary Service Website
Change to Supporting Information: Changed Name, Description
Release: November 2012
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1166, CR1167 and CR1306 (1 November 2012) - ISB 0092 Amd-16-2010 Commissioning Data Set Version 6-2, Commissioning Data Set XML Message Version 6-2 and Retirement of CDS 6-0
- CR1305 (1 April 2013) - ISB 0092 Amd 06/2011 Allied Health Professions Referral to Treatment (AHP RTT) Update - CDS 6-2
- CR1286 (1 November 2012) - ISB 0028 Amd 17/2012 Treatment Function Codes Update
- CR1343 (Immediate) - DDCN 1343/2012 Change of name for NHS Commissioning Board Authority
- CR1342 (Immediate) - DDCN 1342/2012 Overseas Visitors Update
- CR1341 (Immediate) - DDCN 1341/2012 Discharge Default Code Descriptions
- CR1323 (Immediate) - National Cancer Waiting Times Monitoring Data Set Update for "Delay Reason To Treatment For Cancer"
CR1323 is a corrigendum to CR1258 (1 July 2012) - ISB 0147 Amd 23/2011 Changes to the National Cancer Waiting Times Monitoring Data Set published in the June 2012 release
The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2013:
- CR1231 and CR1288 (1 April 2013) - ISB 1570 Amd 164/2010 HIV and AIDS Reporting Data Set and HIV and AIDS Related Data Set Message
Release: September 2012
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1103 (Immediate) - ISB 0066 Amd 43/2010 Renal Data Set - Data Item Addition, Changes and Deletions
- CR1334 (Immediate) - DDCN 1334/2012 Psychology Definitions
- CR1331 (Immediate) - DDCN 1331/2012 Activity Date Time Type
- CR1329 (Immediate) - DDCN 1329/2012 Change of name for "Health and Social Care Information Centre"
Release: August 2012
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1326 (Immediate) - DDCN 1326/2012 Health and Care Professions Council
- CR1241 (Immediate) - DDCN 1241/2012 NHS dictionary of medicines and devices
- CR1292 (Immediate) - ISB 1549 Amd 4/2011 and DDCN 1292/2012 Deprecation and withdrawal of version 3.2 of the Acute Myocardial Infarction Data Set and subsequent retiring of the Data Set from the NHS Data Model and Dictionary
Release: June 2012
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1314 (Immediate) - DDCN 1314/2012 Reasonable Offer Update
- CR1282 (29 June 2012) - ISB 0090 Amd 36/2011 Independent Sector Healthcare Provider (ISHP) Codes extended for ISHPs and Sites
- CR1258 (1 July 2012) - ISB 0147 Amd 23/2011 Changes to the National Cancer Waiting Times Monitoring Data Set
Release: May 2012
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1215 (1 June 2012) - ISB 1067 Amd 30/2011 National Workforce Data Set
The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2013:
- CR1028 (1 April 2013) - ISB 1069 Amd 14/2012 Children and Young People's Health Services Data Set
- CR1029 (1 April 2013) - ISB 1072 Amd 12/2012 Child and Adolescent Mental Health Services (CAMHS) Data Set
- CR1104 (1 April 2013) - ISB 1513 Amd 13/2012 Maternity Secondary Uses Data Set
Release: March 2012
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1242 (Immediate) - DDCN 1242/2012 Retirement of Mental Health Minimum Data Set Version 3
- CR1238 and CR1276 (1 April 2012) - ISB 1577 Amd 10/2011 Diagnostic Imaging Data Set and Diagnostic Imaging Data Set Message v 1-0
- CR1290 (Immediate) - DDCN 1290/2012 Data Set Notation
- CR1263 (Immediate) - ISB 0090 Amd 5/2012 Health and Social Care Bill Changes
- CR1255 (31 March 2012) - ISB 1576 Amd 08/2011 Quarterly Bed Availability and Occupancy Data Set
- CR1295 (Immediate) - Retirement of old Commissioning Data Set messages
The Information Standards Board for Health and Social Care have been involved in the redesign and retirement of the old Commissioning Data Set Pages, however a formal Information Standards Notice (ISN) will not be published as there are no changes to data standards.
Release: January 2012
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1285 (Immediate) - DDCN 1285/2012 Elective Admission Type
- CR1252 (Immediate) - DDCN 1252/2011 Geographic Area Changes
Release: November 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1264 (Immediate) - ISB 1077 Amd 3/2012 Automatic Identification and Data Capture (AIDC) for Patient Identification Data Set
- CR1274 (Immediate) - DDCN 1274/2011 CDS Prime Recipient Identity Update
The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2012:
- CR1265 (1 April 2012) - ISB 1520 Amd 29/2011 Changes to the Improving Access to Psychological Therapies Data Set
Release: October 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1271 (Immediate) - DDCN 1271/2011 Commissioning Data Set Addressing Grid Update
- CR1268 (Immediate) - DDCN 1268/2011 Sexual Orientation Code
The following has been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2012:
- CR1158 and CR1260 (1 April 2012) - ISB 1533 Amd 63/2010 Systemic Anti-Cancer Therapy Data Set and Systemic Anti-Cancer Therapy Data Set Message Schema
The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 July 2012:
- CR1270 (1 July 2012) - ISB 1080 Amd 25/2011 Amendments to NHS Health Check Data Set
- CR1250 (1 July 2012) - ISB 1080 Amd 25/2011 NHS Health Checks Data Set Message Schema Version 2.0.0
Release: August 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1232 (Immediate) - ISB 0034 Amd 26/2006 Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) - NHS Data Model and Dictionary Overview
- CR1222 (1 April 2012) - ISB 0021 Amd 86/2010 Introduction of the International Classification of Diseases Tenth Revision 4th Edition
- CR1190 (1 September 2011) - ISB 1538 Amd 131/2010 Chlamydia Testing Activity Data Set
- CR1188 (Immediate) - Amd 85/2010 Genitourinary Medicine Clinic Activity Data Set (GUMCAD) Extension to include Enhanced Sexual Health Services (ESHS)
The following data set is initially being introduced for local use only. A future Information Standards Notice will be published to notify providers and system suppliers of the requirement to flow the data set nationally:
- CR1105 (1 April 2012) - ISB 1510 Amd 25/2010 Community Information Data Set
Release: July 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1249 (Immediate) - DDCN 1249/2011 General Pharmaceutical Council Registration Changes
The following has been incorporated early to allow users to see the changes, but please note that the implementation date is 1 July 2012:
- CR1148 (1 July 2012) - ISB 1080 Amd 129/2010 NHS Health Checks Data Set
Release: June 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1256 (Immediate) - DDCN 1256/2011 School Definitions
- CR1117 (26 August 2011) - ISB 0090 Amd 94/2010 Organisation Data Service Identification Codes for Local Authorities in England and Wales
- CR1251 (Immediate) - DDCN 1251/2011 Change to the Format/Length of Weekly Hours Worked
- CR1243 (Immediate) - DDCN 1243/2011 National Interim Clinical Imaging Procedure (NICIP) Code Set
Release: April 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1154 (1 April 2011) - ISB 0011 Amd 87/2010 Mental Health Minimum Data Set Version 4.0
- CR1234 (Immediate) - DDCN 1234/2011 Technology Reference Data Update Distribution Service (TRUD)
- CR1168 (Immediate) - ISB 0097 Amd 140/2010 Genitourinary Medicine Access Monthly Monitoring Data Set Amendments - Removal of Human Immunodeficiency Virus data
The following has been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2012:
- CR1050 (1 April 2012) - ISB 1520 Amd 51/2010 Improving Access to Psychological Therapies Data Set
Release: March 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1224 (1 April 2011) - ISB 0092 Amd 02/20110 Commissioning Data Set Schema Version 6-1-1
- CR1223 (Immediate) - DDCN 1223/2011 Updates to Family Planning References
- CR1225 (Immediate) - DDCN 1225/2011 Practitioners with Special Interests
- CR1216 (1 April 2011) - ISB 0028 Amd 170/2010 Changes to Treatment Function Codes
- CR1203 (1 April 2011) - ISB 0084 Amd 150/2010 Introduction of OPCS Classification of Interventions and Procedures Version 4.6
Release: January 2011
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:- CR1116 (1 April 2010) - ISB 0003 Amd 79/2010 Immunisation Programmes Activity Data Set (KC50)
- CR1112 (1 April 2010) - ISB 1511 Amd 26/2010 NHS Continuing Healthcare and NHS Funded Nursing Care
- CR1068 (Immediate) - ISB 0133 Amd 161/2010 Change To Central Return: Human Papillomavirus (HPV) Immunisation Programme - Vaccine Monitoring Minimum Data Set
- CR1211 (Immediate) - DDCN 1211/2010 Commissioning Data Set Addressing Grid / Organisation Code (Code of Commissioner) Update
Release: December 2010
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1175 (1 April 2011) - ISB 1518 Amd 166/2010 Changes to Sexual and Reproductive Health Activity Data Set
- CR1198 (Immediate) - ISB 1067 Amd 165/2010 National Workforce Data Set
- CR1207 (01 December 2010) - ISB 1573 Amd 168/2010 Mixed-Sex Accommodation
- CR1149 (01 January 2011) - ISB 0139 Amd 99/2010 GUMCAD: Change to Genitourinary (GU) Episode Types
Release: November 2010
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1119 (Immediate) - DDCN 1119/2010 Organisation Codes Update
- CR1192 (Immediate) - DDCN 1192/2010 Change of name for "Health Solution Wales"
- CR1199 (Immediate) - DDCN 1199/2010 General Pharmaceutical Council and Royal Pharmaceutical Society of Great Britain Update
- CR1189 (Immediate) - DDCN 1189/2010 National Institute for Health and Clinical Excellence
- CR1187 (Immediate) - DDCN 1187/2010 Introduction of the Department for Education
Release: September 2010
Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1128 (Immediate) - DDCN 1128/2010 Changes to reporting procedures for Overseas Visitors from the European Economic Area and Switzerland
- CR1173 (Immediate) - DDCN 1173/2010 Care Quality Commission Update
- CR1143 (Immediate) - DDCN 1143/2010 General Pharmaceutical Council
- CR1061 (1 October 2010) - ISB 0092/2010 CDS Type 20: Out-patient: Retirement of Default Codes for Out-patient Procedures
- CR1133 (Immediate) - ISB 00289/2010 National Specialty List
Release: August 2010
- The August 2010 Release introduces the NHS Data Model and Dictionary Help Pages.
Release: July 2010
Information Standards Notices and Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1134 (Immediate - ISB 1067/2010 Amd 109/2010 National Workforce Data Set
- CR1082 (Immediate) - ISB 0153/2010 Critical Care Minimum Data Set
- CR1121 (Immediate) - DSCN 17/2010 Retirement of Data Standard KC60 Central Return
Release: May 2010
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR957 (Immediate) - DSCN 19/2010 Central Returns: KA34 Ambulance Services
- CR1069 (Immediate) - Redesign of the Commissioning Data Set Pages
The Information Standards Board for Health and Social Care have been involved in the redesign of the Commissioning Data Set Pages and are satisfied that it meets the requirements of the service, however a formal Information Standards Notice (ISN) will not be published as there are no changes to data standards.
Release: March 2010
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1123 (1 April 2010) - DSCN 18/2010 Information Standards Notice (ISN)
- CR1139 (Immediate) - DSCN 16/2010 Person Weight
- CR1130 (Immediate) - DSCN 15/2010 Change of name for "The NHS Information Centre for health and social care"
- CR1013 (April 2010) - DSCN 14/2010 Sexual and Reproductive Health Activity Dataset (SRHAD)
- CR1125 (Immediate) - DSCN 13/2010 NHS Data Model and Dictionary Maintenance Update - Policy Definitions
- CR1122 (Immediate) - DSCN 11/2010 Changes to Family Planning References
Release: January 2010
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1115 (Immediate) - DSCN 10/2010 Data Standards: Updating of e-Government Interoperability Framework and Government Data Standards Catalogue References
Release: December 2009
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1100 (Immediate) - DSCN 25/2009 NHS Prescription Services Update
- CR1045 (1 December 2009) - DSCN 17/2009 Referral to Treatment Clock Stop Administrative Event
- CR1003 (1 December 2009) - DSCN 16/2009 Commissioning Data Sets: Mandation of 18 Week Referral To Treatment Data Items
Release: November 2009
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1113 (Immediate) - DSCN 24/2009 Information Standards Board for Health and Social Care Update
- CR1087 (Immediate) - DSCN 23/2009 Health Professions Council Update
- CR1081 (Immediate) - DSCN 22/2009 Data Standards: NHS Data Model and Dictionary Maintenance Update
- CR1019 (27 November 2009) - DSCN 21/2009 Data Standards: Organisation Data Service (ODS) - Optical Sites and Optical Headquarters
- CR1034 (27 November 2009) - DSCN 20/2009 Data Standards: Organisation Data Service (ODS) - Care Homes in England and Wales and their Headquarters
Release: September 2009
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1065 (1 October 2009) - DSCN 15/2009 Data Standards: Organisation Data Service, Local Health Boards
Release: June 2009
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1014 (1 June 2009) - DSCN 13/2009 Religious and Other Belief System Affiliation
- CR1074 (Immediate) - DSCN 12/2009 Data Standards: Care Quality Commission
- CR1056 (Immediate) - DSCN 11/2009 Data Standards: NHS Data Model and Dictionary Maintenance Update
- CR1072 (1 December 2009) - DSCN 10/2009 Data Standards: National Radiotherapy Data Set
- CR1073 (Immediate) - DSCN 09/2009 Central Returns: Diagnostic Waiting Times and Activity Data Set
- CR1066 (Immediate) - DSCN 08/2009 Data Standards: NHS Prescription Services and NHS Dental Services
- CR1047 (1 April 2011) - DSCN 07/2009 Data Standards: Diabetic Retinopathy Screening Dataset v3.6
- CR1059 (Immediate) - DSCN 06/2009 Data Standard: National Workforce Data Set v2.1
- CR914 (April 2008 (Retrospective)) - DSCN 05/2009 NHS Stop Smoking Services Quarterly Monitoring Return
- CR899 (Immediate) - DSCN 02/2009 NHS Data Model and Dictionary Maintenance Update
Release: March 2009
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1001 (1 April 2009) - DSCN 03/2009 Introduction of Commissioning Data Set Schema Version 6-1 (2008-04-01) and update to Commissioning Data Set Schema Version 6-0 (2008-01-14)
- CR976 (31 March 2009) - DSCN 26/2008 Subject: KP90 - Admissions, Changes in Status and Detentions under the Mental Health Act
- CR1017 (1 April 2009) - DSCN 25/2008 Critical Care Minimum Data Set
- CR1002 (1 April 2009) - DSCN 24/2008 Data Standards: Introduction of Commissioning Dataset Version 6.1
- CR1016 (Immediate) - DSCN 23/2008 4 Byte Version of the Read Codes - Withdrawal
Release: December 2008
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1022 (1 January 2009) - DSCN 29/2008 Data Standards: 18 Weeks Referral to Treatment (RTT) Time, Performance Sharing
- CR901 (Immediate) - DSCN 28/2008 Removal of references to EDIFACT and the NHS Wide Clearing Service (NWCS)
- CR843 (1 April 2009) - DSCN 22/2008 Data Standards: National Radiotherapy Data Set
- CR1011 (1 January 2009) - DSCN 20/2008 Data Standards: National Cancer Waiting Times Minimum Data Set
Release: November 2008
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1026 (3 November 2008) - DSCN 21/2008 Information Standard: Mental Health Act 2007 Mental Category
Release: August 2008
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR1018 (Immediate) - DSCN 19/2008 Data Standards: Change of Name for National Administrative Code Services (NACS) to Organisation Data Service (ODS)
- CR956 (1 September 2008) - DSCN 18/2008 Central Return: Human Papillomavirus (HPV) Immunisation Programme, Vaccine Monitoring Minimum Dataset
- CR861 (Immediate) - DSCN 16/2008 Central Return: Hospital and Community Services Complaints and General Practice (including Dental) Complaints - KO41(a) and KO 41(b)
- CR964 (Immediate) - DSCN 14/2008 Central Return: 18 Weeks ‘Adjusted’ Referral to Treatment (RTT) Dataset
- CR965 (Immediate) - DSCN 13/2008 Data Standards: Organisation Data Service (ODS) - Change to the Default Codes Set to Support Changes to GMS Contract
- CR879 (Immediate) - DSCN 12/2008 Data Standards: Quarterly Monitoring: Cancelled Operations Data Set (QMCO)
Release: May 2008
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR502 (Immediate) - DSCN 10/2008 Data Standards: National Workforce Data Definitions (v2.0)
- CR910 (1 April 2008) - DSCN 08/2008 Data Standards: National Direct Access Audiology Patient Tracking List (PTL) and Waiting Times (WT) data sets
- CR900 (Immediate) - DSCN 07/2008 Data Standards: Inter-Provider Transfer Administrative Minimum Data Set
- CR934 (1 April 2008) - DSCN 06/2008 Data Standards: Mental Health Minimum Data Set (version 3.0)
- CR935 (Immediate) - DSCN 05/2008 Data Standards: 18 Weeks Rules Suite
- CR925 (1 September 2008) - DSCN 04/2008 Genitourinary Medicine Clinic Activity Data Set Change to an Information Standard
- CR942 (1 June 2008) - DSCN 03/2008 General Practice and General Medical Practitioner (GMP) - changes resulting from the introduction of the General Medical Services (GMS) Contract
Release: February 2008
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR812 (Immediate) - DSCN 01/2008 Central Return: Diagnostics Waiting Times Census Data Set
- CR881 (31 December 2007) - DSCN 42/2007 Central Return: Referral To Treatment Summary Patient Tracking List
- CR904 (Immediate) - DSCN 41/2007 Data Standards: Admission Intended Procedure Update
- CR824 (1 February 2008) - DSCN 39/2007 Data Standards: 48 Hour Genitourinary Medicine Access Monthly Monitoring (GUMAMM)
Release: November 2007
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR919 (Immediate) - DSCN 38/2007 Data Standards: Mental Health Minimum Data Set Schema
- CR814 (1 April 2008) - DSCN 37/2007 Data Standards: Introduction of Mental Health Minimum Data Set version 2.1
- CR930 (31 December 2007) - DSCN 35/2007 Data Standards: A correction to the version 6 Commissioning Data Set schema
- CR834 (Immediate) - DSCN 34/2007 Data Standards: Referral Request Received Date
- CR875 (Immediate) - DSCN 33/2007 Data Standards: National Administrative Codes Service: Introduction of codes for the new Pan SHAs
- CR880 (Immediate) - DSCN 29/2007 Data Standards: Amendments to Doctor Index Number (DIN) Description
Release: August 2007
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR845 (Immediate) - DSCN 28/2007 Data Standards: Treatment Function Code (Referral to Treatment Period)
- CR831 (1 October 2007) - DSCN 27/2007 Data Standards: Update to Commissioning Data Set XML Schema v5
- CR825 (1 October 2007) - DSCN 16/2007 Data Standards: Source of Referral for Outpatients (18 Weeks)
Release: June 2007
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR799 (31 December 2007) - DSCN 18/2007 Data Standards: Introduction of Commissioning Data Set Version 6
- CR833 (Immediate) - DSCN 17/2007 Data Standards: Introduction of Commissioning Data Set validation table
- CR801 (Immediate) - DSCN 15/2007 Data Standards: Cover of Vaccination Evaluated Rapidly (COVER) Return
Release: May 2007
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR800 (31 December 2007) - DSCN 14/2007 Commissioning Data Set Schema Version 6-0
- CR856 (1 October 2007) - DSCN 13/2007 Data Standards: Discharge Ready Date
- CR869 (Immediate) - DSCN 12/2007 Data Standards: Update to Clinical Coding Introduction
- CR827 (1 October 2007) - DSCN 09/2007 Data Standards: Earliest Reasonable Offer Date
- CR817 (1 October 2007) - DSCN 08/2007 Data Standards: Introduction of Age into Commissioning Data Sets
- CR849 (May 2007) - DSCN 07/2007 National Administrative Codes Service: Introduction of new identification codes for Dental Consultants
- CR822 (Immediate) - DSCN 06/2007 Data Standards: Update to Organisation Codes
- CR850 (Immediate) - DSCN 05/2007 National Administrative Codes Service: Amendments to Default Codes
- CR786 (1 April 2007) - DSCN 04/2007 Quarterly Monitoring Accident and Emergency Services (QMAE) Central Return
Release: February 2007
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR811 (Immediate) - DSCN 03/2007 Diagnostic Waiting Times and Activity
- CR826 (1 October 2007) - DSCN 02/2007 Extension of Treatment Function to Support the Measurement of 18 Week Referral to Treatment Periods
- CR813 (1 April 2007) - DSCN 01/2007 Paediatric Critical Care Minimum Data Set
- CR768 (1 January 2007) - DSCN 18/2006 Changes to the NHS Data Dictionary to support the measurement of 18 week referral to treatment periods
- CR798 (6 November 2006) - DSCN 19/2006 Commissioning Data Set (CDS) Version 5 XML Message Schema
- CR776 (1 October 2006) - DSCN 05/2006 Data Standards: Accident and Emergency Enhancements to Investigation and Treatment Codes
Release: September 2006
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR795 (31 October 2006) - DSCN 22/2006 Organisation Codes / Organisation Site Codes
- CR792 (1 April 2007) - DSCN 15/2006 Neonatal Critical Care
- CR719 (1 April 2006) - DSCN 09/2006 Measuring and Recording of Waiting Times
- CR791 (1 April 2007) - DSCN 13/2006 Priority Type
- CR774 (1 September 2006) - DSCN 12/2006 Person Marital Status
Release: May 2006
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR764 (1 April 2006) - DSCN 08/2006 Diagnostics waiting times and activity
- Correction to menu structure to include Critical Care Minimum Data Set
Release: April 2006
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR608 (1 October 2006) - DSCN 07/2006 Introduction of Commissioning Data Set Version 5 and its associated XML schema into the NHS Data Dictionary.
- CR756 (1 September 2005) - DSCN 19/2005 PbR Commissioning for Out of Area Treatments (OATs) and Charge-Exempt Overseas Visitors
- CR724 (1 April 2006) - DSCN 13/2005 Critical Care Minimum Data Set
- CR754 (1 April 2006) - DSCN 17/2005 Treatment Function and Main Specialty Code Revisions
- CR763 (1 April 2006) - DSCN 20/2005 New Treatment Functions for therapy services and anticoagulant service
- CR767 (Immediate) - DSCN 02/2006 Referral Request Received Date
- CR690 (1 September 2005) - DSCN 16/2005 Marital Status
Release: August 2005
Data Set Change Notices incorporated into the NHS Data Model and Dictionary:
- CR555 (1 April 2005) - DSCN 11/2005 Data Standards: COVER - Hepatitis B immunisation for babies
- CR715 (Immediate) - DSCN 10/2005 Data Standards: Treatment Function Codes - correction and clarification of names and descriptions
- CR706 (1 April 2005) - DSCN 09/2005 Data Standards: Cancer Registration Data Set
- CR691 (1 July 2005) - DSCN 06/2005 Data Standards: NSCAG Commissioner Code
For all Information Standards Notices and Data Set Change Notices, see the Information Standards Board for Health and Social Care Website
Change to Attribute: Changed Description
An ACTIVITY may have many DATES AND TIMES associated with it but may only have one DATE AND TIME of a particular type.
National Codes:
Note: This list is not in alphabetical order.
Change to Attribute: Changed Description
This indicates whether an APPOINTMENT for a CARE CONTACT took place.An indication of whether an APPOINTMENT for a CARE CONTACT took place.
If the APPOINTMENT did not take place it also indicates if advance warning was given.
When an APPOINTMENT is cancelled the APPOINTMENT CANCELLED DATE should also be recorded.
National Codes:
5 | Attended on time or, if late, before the relevant CARE PROFESSIONAL was ready to see the PATIENT |
6 | Arrived late, after the relevant CARE PROFESSIONAL was ready to see the PATIENT, but was seen |
7 | PATIENT arrived late and could not be seen |
2 | APPOINTMENT cancelled by, or on behalf of, the PATIENT |
3 | Did not attend - no advance warning given |
4 | APPOINTMENT cancelled or postponed by the Health Care Provider |
0 | Not applicable - APPOINTMENT occurs in the future * |
Note: The classification has been listed in logical sequence rather than alphanumeric order.
* Note that code 0 - 'Not applicable - APPOINTMENT occurs in the future' is NOT valid for use in the following data sets:
Use in the Future Outpatient Commissioning Data Set:
- For referral records with no APPOINTMENT yet made, or for future APPOINTMENTS, code 0 - Not applicable - APPOINTMENT occurs in the future should be used.
- Where the future attendance has been cancelled, use the appropriate value from the National Codes.
Change to Attribute: Changed Description
The type of CURRENCY used in a financial amount.
National Codes:
GBP | Pound Sterling |
USD | US Dollar |
EUR | Euro |
Refer to BSEN 4217 for actual lists of codes and names Note: ISO standard no longer contains obsolete euro-zone currencies (plus 'Milk Tokens' for the Department for Work and Pensions (DWP)).
References:
The e-GIF version approved for use in NHS England is:
Government Data Standards Catalogue: (GDSC), Version 2.0, Agreed 1 January 2002.
Further information can be found on the Cabinet Office website.
Change to Attribute: Changed Description
An indicator of whether the birth was a live or still birth. A still birth is a birth after a gestation of 24 weeks (168 days) where the baby shows no identifiable signs of life at delivery.An indication of whether the birth was a live or still birth.
A still birth is a birth after a gestation of 24 weeks (168 days) where the baby shows no identifiable signs of life at delivery.
National Codes:
1 | Live |
2 | Still birth ante-partum |
3 | Still birth intra-partum |
4 | Still birth indeterminate |
Change to Attribute: Changed Description
The type of measurement used for the MEASURED PERSON OBSERVATION being recorded.
The unit of measurement is based on the MEASURED PERSON OBSERVATION TYPE CODE for that MEASURED PERSON OBSERVATION.
National Codes:
01 | Millimoles per litre (mmol/L) |
02 | Micromoles per litre (µmol/L) |
03 | Micrograms per litre (ug/L) |
04 | Micrograms per millimole (ug/mmol) |
05 | Microgram albumin per hour (ug/ml/hr) |
06 | Microgram albumin per minute (ug/min) |
07 | Microgram albumin per 24 hours (ug/24hr) |
08 | Number |
09 | Percentage (%) |
10 | Kilograms (kg) |
11 | Metres (m) |
13 | Square Metres (m2) |
14 | Millilitres per Minute (ml/min) |
15 | Millimetre of mercury (mmHg) |
16 | Litres (l) |
17 | Beats per minute (bpm) |
18 | Centimetres (cm) |
19 | Milligrams (mg) |
20 | Millilitres (ml) |
21 | Minutes |
22 | Celsius |
Change to Attribute: Changed Description
An ORGANISATION CODE is a code which identifies an ORGANISATION uniquely.
For NHS ORGANISATIONS it is a code that is managed by either the:
to identify most ORGANISATIONS that exchange information within the NHS or return information to the Centre. Examples of ORGANISATIONS that can be identified this way are Primary Care Trusts and Strategic Health Authorities.
Notes:
- Organisation Data Service codes can be downloaded:
- from the Organisation Data Service website for NHS staff only and
- via files issued on the Technology Reference Data Update Distribution Service (TRUD) website
- Organisation Data Service contact details can be found at Contact Details.
ORGANISATION CODING FRAMES
- All NHS ORGANISATIONS are coded using coding frames, as shown in the tables below:
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
Format | a/n | a/n | a/n | a/n | a/n | a/n | a/n | a/n |
A Frame | Organisation | Organisation Identifier | ||||||
B Frame | Organisation Type Identifier | Organisation Identifier | ||||||
C Frame | Organisation Type Identifier | Organisation Identifier | ||||||
D Frame | Organisation Type Identifier | Organisation Identifier | ||||||
E Frame | Organisation Identifier | |||||||
F Frame | Organisation Type Identifier | Organisation Identifier | ||||||
G Frame | Organisation Type Identifier | Practice Identifier | ||||||
H Frame | Organisation Type Identifier | Organisation Identifier | ||||||
I Frame | Organisation Type Identifier | Organisation Identifier | ||||||
J Frame | Organisation Type Identifier | Organisation Identifier | ||||||
K Frame | Organisation Identifier | |||||||
L Frame | Organisation Type Identifier | Organisation Identifier | Organisation Type Identifier | |||||
M Frame | Organisation and Organisation Type Identifier |
NHS Organisations:
A Frame:
Example
Independent Provider (IP) e.g. 8HA03
- 8 = Organisation Type Identifier
- Remainder of code identifies organisation
Also:
Cancer Registry | e.g. Y0401 |
Primary Care Group/Local Health Group (now all closed) | e.g. 4AA24 |
B Frame:
Example
Local Service Provider e.g. LSP01
- LSP = Organisation Type Identifier
- 01 = Organisation Identifier
Also:
Application Service Provider | e.g. YGM01 |
Education (Deanery) | e.g. YDF01 |
NHS Support Agencies | e.g. YDD01 |
Workforce Development Confederation (All closed June 2006) | e.g. LWF03 |
C Frame:
Example
School e.g. EE134290
- EE = Organisation Type Identifier
- Remainder of code identifies organisation
D Frame:
Example
Strategic Health Authority e.g. Q30
- Q = Organisation Type Identifier
- 30 = Organisation Identifier
Also:
Care Trust | e.g. TAK |
Local Health Board (Wales) | e.g. 7A1 |
NHS Trust | e.g. RH8 |
Primary Care Trust | e.g. 5CT |
Welsh Local Health Board (All closed 30 September 2009) | e.g. 6C4 |
E Frame:
Example
Government Office Region (GOR) e.g. K
- K = Organisation Identifier
F Frame:
Example
Pharmacy HQ e.g. P001
- P = Organisation Type Identifier
- 001 = Organisation Identifier
Also:
Care Home Headquarters | e.g.CA0A |
Local Authority Please Note: The Local Authority codes are not available for general use but must only be used to facilitate Spine Smartcard and Endpoint Registration. | e.g.V001 |
Optical Headquarters | e.g.T1A1 |
G Frame:
Example
GP Practice e.g. Y00001
- Y = Organisation Type Identifier
- 00001 = Practice Identifier
Also:
General Dental Practice | e.g.V20052 |
H Frame:
Example
Cancer Network e.g. N01
- N0 (where the 2nd character is numeric and not alpha) = Organisation Type Identifier
- 1 = Organisation Identifier
Also:
Booking Management System (BMS) Call Centre Establishment | e.g. YF1 |
Government Department | e.g. XDA |
Independent Sector Healthcare Provider (ISHP) (where the 2nd character is alpha) | e.g. NV7 |
IT Cluster (ITC) (All closed in England on 31 March 2007) | e.g. Y41 |
National Application Service Provider (NASP) (NPfIT) | e.g. YEA |
Other Statutory Authority (OSA) | e.g. X16 |
Pan SHA | e.g. Y51 |
I Frame:
Example
Special Health Authority (SpHA) e.g. T1150
- T1 = Organisation Type Identifier
- 150 = Organisation Identifier
J Frame:
Example
Transplant Consortium e.g. Y01T1
- Y01T = Organisation Type Identifier
- 1 = Organisation Identifier
K Frame:
Example
NHS Wales Informatics Service e.g. W00
- W00 = Organisation Identifier
L Frame:
Example
Local Commissioning Group (Northern Ireland) e.g. ZC010
- Characters 1-3 (ZC0) AND character 5 (0) = Organisation Type Identifier
- Character 4 identifies organisation
Note: this is a 5 character method of displaying Local Commissioning Group (Northern Ireland) identifiers.
Characters 3 and 5 are ‘fillers’. If a 3 character code is required (as used by the Office for National Statistics in the NHS Postcode Directory) zeros can be omitted, e.g. ZC1.
The 3 character method of displaying the Local Commissioning Group (Northern Ireland) identifiers fit under the H Frame.
Guidance on the use of Northern Ireland codes can be found in Data Set Change Notice 19/2009.
M Frame:
Example
Clinical Commissioning Group (CCG) From April 2013 e.g. 12A
- 12A = Organisation and Organisation Type Identifier
The structure and format of ORGANISATION CODES maintained by the Organisation Data Service, NHS Prescription Services, NHS Dental Services and other agencies are detailed in the tables below.
ORGANISATION CODES TABLES
Table 1: CODING FORMATS FOR ORGANISATIONS IN ENGLAND AND WALES
ORGANISATION CODES for England and Wales are published by the Organisation Data Service and can be found:
- on their website at: http://nww.connectingforhealth.nhs.uk/ods/downloads for NHS staff only and
- via files issued on the Technology Reference Data Update Distribution Service (TRUD) website.
Organisation Type | Frame Type | Character Position | Code allocated by: | Notes/Comments | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||||
Application Service Provider | B | Y | G | M | A-9 | A-9 | e.g. YGM01 | ||||
Booking Management System (BMS) Call Centre Establishment | H | Y | F | A-9 | e.g. YF1 | ||||||
Cancer Network | H | N | 0-9 | A-9 | e.g. N01 | ||||||
Cancer Registry | A | Y | A-9 | A-9 | A-9 | A-9 | e.g. Y0401 | ||||
Care Home Headquarters | F | A, C or D | A-9 | A-9 | A-9 | e.g. CA0A | |||||
Care Trust (CT) | D | T | A-Y | A-Y | e.g. TAK | ||||||
Clinical Commissioning Group (CCG) | M | 0-9 | 0-9 | A-Y | From April 2013 e.g. 12A | ||||||
|
|
|
|
|
| ||||||
Directorate of Health and Social Care (DHSC) | N/A All Closed | Y | 2 | 0-9 | DHSCs in England all closed in June 2003 e.g. Y21 | ||||||
Education (Deanery) | B | Y | D | F | A-9 | A-9 | e.g. YDF01 | ||||
Executive Agency | N/A See Note 1 | X | 0-9 | 0-9 | e.g. X09 | ||||||
Executive Agency Programme | N/A See Note 1 | X | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | First three characters denote Executive Agency e.g. X09001 | |||
General Dental Practice - England and Wales | G | V | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | e.g. V20052 | |||
Government Department | H | X | A-Y | A-Y | e.g. XDA | ||||||
E | A-Y | e.g. K Government Office Regions (GORs) closed 31 March 2011 - from 1 April 2011 referred to as Regions | |||||||||
GP Practice - England and Wales | G | A-H, | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | Char 1 = W for Welsh GP Practice. From 2003, ALL newly allocated Practice Codes begin with a Y" e.g. Y00001 | |||
A | 8 | A-Y | A-9 | 0-9 | 0-9 | ODS - England | Character 2: W - Wales. All other values represent England. e.g. 8HA03 | ||||
|
|
|
|
| |||||||
|
|
|
|
|
| ||||||
H | A, B, D, G, I, K, L, M , N, O, S, U, V, W | A-Y | A-Y, 0-9 | e.g. NV7 | |||||||
IT Cluster (ITC) | H | Y | 4 | 0-9 | e.g. Y41 All IT Clusters in England closed on 31 March 2007 | ||||||
F | V | A-9 | A-9 | A-9 | e.g. V001 | ||||||
L | Z | C | 0 | 0-9 | 0 | Department for Health, Social Services and Public Safety (DHSSPS), Northern Ireland | e.g.ZC010 Note that characters 3 and 5 are ‘fillers’ to create a 5 character code. If a 3 character code is required (as used by the Office for National Statistics in the NHS Postcode Directory), zeros can be omitted and fits under the H frame: e.g. ZC1. | ||||
B | 7 | A-9 | A-9 | e.g. 7A1 | |||||||
Local Service Provider (LSP) | B | L | S | P | 0-9 | 0-9 | e.g. LSP01 | ||||
National Application Service Provider (NASP) (NPfIT) | H | Y | E | A-9 | e.g. YEA | ||||||
NHS Support Agencies (Shared Services and Health Informatics Services) | B | Y | D | D | A-9 | A-9 | e.g. YDD01 | ||||
D | R | A-9 | A-9 | e.g. RH8 | |||||||
K | W | 0 | 0 | Only one organisation of this type exists for Wales e.g. W00 | |||||||
F | T | 0-9 | A-9 | A-9 | e.g. T1A1 | ||||||
H | X | 0-9 | 0-9 | e.g. X16 | |||||||
Pan SHA | H See Note 2 | Y | 5 | 0-9 | e.g. Y51 | ||||||
Pharmacy HQ | F | P | A-9 | A-9 | A-9 | e.g. P001 | |||||
|
|
|
|
|
|
|
| ||||
Primary Care Group/ Local Health Group | A | 4 | A-Y | A-Y | 0-9 | 0-9 | Primary Care Groups in England and Local Health Groups in Wales PCGs all closed by March 2002 e.g. 4AA24 | ||||
D | 5 | A-9 | A-9 | e.g. 5CT | |||||||
C | E | E | A-9 | A-9 | A-9 | A-9 | A-9 | A-9 | e.g. EE134290 | ||
I | T | 1 | 0-9 | 0-9 | 0 | e.g. T1150 | |||||
D | Q | A-9 | A-9 | Strategic Health Authorities in England e.g. Q30 | |||||||
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
| ||||
Transplant Consortium | J | Y, S, W or Z | 0-9 | 0-9 | T | 0-9 | English Transplant Consortiums are all Closed England = Y, Scotland = S, Wales = W and N.Ireland = Z e.g. Y01T1 | ||||
Welsh Local Health Board (WLHB) | D | 6 | A-Y | 0-9 | e.g. 6C4 All Welsh Local Health Boards closed on 30 September 2009 Local Health Boards introduced from 1 October 2009 | ||||||
Workforce Development Confederation | B | L | W | F | A-9 | A-9 | e.g. LWF03 All closed June 2006 |
Note 1: Codes for Executive Agency, Executive Agency Programme, Executive Agency Site and Executive Agency Programme Department do not easily fit into the coding frames as shown above and are therefore not included. This is due to their unusual structure in that there are more hierarchical 'tiers' than with other organisations.
Executive Agency and Executive Agency Programme are both considered Organisation level entities, although each Programme does have a relationship to an Executive Agency. Executive Agency codes are three characters long. Executive Agency Programme codes are six, and their first three characters are the same as the Executive Agency they are associated to.
Department codes of eight characters long can then be allocated underneath a Programme code (sharing the first six characters). Executive Agency Site codes of five characters long can be allocated under an Executive Agency code (and share the first three characters).
Note 2: The Pan SHAs are made up of confederations of SHAs and as such, are Health Areas, not organisations. However, it has been recognised that these health areas do require codes in order that NHS systems continue to function.
Note: A-9 indicates that characters A-Z and 0-9 are valid: except B, I, O, S, U and Z (to avoid ambiguity). This applies to all ORGANISATION CODES in the Coding Format Table above except Independent Sector Healthcare Providers (ISHP).
Table 2: CODING FORMATS FOR ORGANISATIONS IN SCOTLAND
Scottish ORGANISATION CODES are supplied by the Information Standards Directorate from NHS Scotland and published by the Organisation Data Service:
- on their website at: http://nww.connectingforhealth.nhs.uk/ods/downloads/scotdown/ for NHS staff only and
- via files issued on the Technology Reference Data Update Distribution Service (TRUD) website.
Organisation Type | Character Position | Code allocated by: | Notes/Comments | |||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |||
GP Practice - Scotland | S | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | NHS | |
Scottish GP Fundholder | S | A-Z | B | 0-9 | 0-9 | ISD, Scotland | 2nd character identifies the Health Board the GPFH reports to. | |
Scottish Health Agency | S | D | 0-9 | 0-9 | 0-9 | ISD, Scotland | 2nd character (D) identifies Scottish Office agencies | |
Scottish Health Board | S | A-Z | 9 | 9 | 9 | ISD, Scotland | ||
Scottish Provider | S | A-Z | A,C,D | 0-9 | 0-9 | ISD, Scotland | 2nd character identifies the Health Board the organisation reports to. |
Table 3: CODING FORMATS for ORGANISATIONS in OTHER HOME COUNTRIES
ORGANISATION CODES for Isle of Man Government Departments, Directorates and Sites are published by the Organisation Data Service and can be found:
- on their website at: http://nww.connectingforhealth.nhs.uk/ods/downloads/iomdown for NHS staff only and
- via files issued on the Technology Reference Data Update Distribution Service (TRUD) website.
Organisation Type | Character Position | Code allocated by: | Notes/Comments | |||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |||
GP Practice - Alderney | A | L | D | 0-9 | 0-9 | 0-9 | ||
GP Practice - Guernsey | G | U | E | 0-9 | 0-9 | 0-9 | ||
GP Practice - Isle of Man (IOM) | Y | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | ||
GP Practice - Jersey | J | E | R | 0-9 | 0-9 | 0-9 | ||
Isle of Man (IOM) Government Department | Y | J | A-9 | e.g. YJM | ||||
Y | K | A-9 | e.g. YK1 |
Note: A-9 indicates that characters A-Z and 0-9 are valid: except B, I, O, S, U and Z (to avoid ambiguity).
Change to Attribute: Changed Description
An ORGANISATION SITE CODE is a code which identifies an ORGANISATION SITE uniquely.
Note: Only ORGANISATION SITE CODES which have been notified to and issued by the Organisation Data Service may be used.
Notes:
- Organisation Data Service codes can be downloaded:
- from the Organisation Data Service website for NHS staff only and
- via files issued on the Technology Reference Data Update Distribution Service (TRUD) website
- Organisation Data Service contact details can be found at Contact Details.
ORGANISATION SITE CODING FRAMES
- All NHS ORGANISATION SITES are coded using coding frames, as shown in the tables below:
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
---|---|---|---|---|---|---|---|---|---|
Format | a/n | a/n | a/n | a/n | a/n | a/n | a/n | a/n | a/n |
A Frame | Organisation Type Identifier | Organisation Identifier | Site or Sub-Division Identifier | ||||||
B Frame | Organisation Type Identifier | Organisation Identifier | Site or Sub-Division Identifier | ||||||
C Frame | Organisation Type Identifier | Organisation Identifier | Site or Sub-Division Identifier | ||||||
D Frame | Organisation Type | Practice Identifier | Branch Surgery Identifier | ||||||
E Frame | Organisation Type Identifier | Organisation Identifier | Site or Sub-Division Identifier | ||||||
F Frame | Organisation Type | Organisation Identifier | |||||||
G Frame | Organisation Type | Organisation Identifier | Site or Sub-Division Identifier | ||||||
H Frame | Organisation Type Identifier | Organisation Identifier | |||||||
I Frame | Organisation Type Identifier | Organisation Identifier | |||||||
J Frame | Organisation Type Identifier | Organisation Identifier | |||||||
K Frame | Organisation and Organisation Type Identifier | Organisation Site Identifier |
NHS Organisation Sites:
A Frame:
Example
Local Service Provider Site e.g. LSP0101
- LSP = Org Type Identifier
- 01 = Organisation Identifier
- 01 = Site or sub-division
B Frame:
Example
Strategic Health Authority Site e.g. Q3001
- Q = Organisation Type Identifier
- 30 = Organisation Identifier
- 01 = Site or sub-division
Also:
Primary Care Trust Site | e.g. 5CT49 |
Care Trust Site | e.g. TAK01 |
Other Statutory Authority (OSA) Site | e.g. X1601 |
NHS Trust Site | e.g. RH802 |
Government Department Site | e.g. XDA01 |
Local Health Board (Wales) Site | e.g. 7A101 |
Welsh Local Health Board Site (all closed 30 September 2009) | e.g. 6C401 |
Treatment Centre | e.g. 5CG12 |
C Frame:
Example
Independent Sector Healthcare Provider (ISHP) Site e.g. NV701
- NV = Organisation Site Type Identifier
- 7 = Organisation Identifier
- 01 = equals site or sub-division
Also:
Primary Healthcare Directorate (Isle of Man) Site | e.g. YK101 |
D Frame
Example
GP Practice Branch Surgery: e.g. H81010002
- H (and length of code) = Organisation Identifier
- 81010 = Organisation Identifier (parent GP Practice)
- 002 = Branch Surgery Identifier
E Frame
Example
Special Health Authority (SpHA) Site: e.g. T115A
- T1 = Organisation Type Identifier
- 15 = Organisation Identifier
- A = Site or Sub-Division Identifier
F Frame
Example
Dispensary: e.g. FA002
- F = Organisation Type Identifier
- A002 = Organisation Identifier
G Frame
Example
Local Authority Site: e.g. V001AA
- V = Organisation Type Identifier
- 001 = Organisation Identifier
- AA = Site or Sub-Division Identifier
Please Note: The Local Authority codes are not available for general use but must only be used to facilitate Spine Smartcard and Endpoint Registration.
H Frame
Example
Prison: e.g. YDE01
- YDE = Organisation Type Identifier
- 01 = Site or Sub-Division Identifier
I Frame
Example
Optical Site: e.g. TP01A,
- TP = Organisation Type Identifier
- 01A = Site or Sub-Division Identifier
J Frame
Example
Care Home Site: e.g. VN01A
- VN = Organisation Type Identifier
- 01A = Site or Sub-Division Identifier
K Frame
Example
Clinical Commissioning Group (CCG) Site From April 2013, e.g. 11AAA - 99YZZ
- 11A = Organisation and Organisation Type Identifier
- AA = Organisation Site Identifier
The structure and format of ORGANISATION SITE CODES maintained by the Organisation Data Service, NHS Prescription Services and other agencies are detailed in the tables below.
NHS ORGANISATION SITE CODES TABLES
Coding Formats
Table 1: CODING FORMATS FOR ORGANISATION SITES IN ENGLAND AND WALES
ORGANISATION SITE CODES for England and Wales are published by the Organisation Data Service and can be found:
- on their website at: http://nww.connectingforhealth.nhs.uk/ods/downloads for NHS staff only and
- via files issued on the Technology Reference Data Update Distribution Service (TRUD) website.
Organisation Type | Frame Type | Character Position | Code allocated by: | Notes/Comments | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||||
Care Home Site | J | V | L, M or N | A-9 | A-9 | A-9 | e.g. VN01A, VM01A, VL01A | |||||
Care Trust Site | B | T | A-Y | A-Y | A-9 | A-9 | First three characters denote owning Care Trust e.g. TAK01 | |||||
Clinical Commissioning Group (CCG) Site From April 2013 | K | 0-9 | 0-9 | A-Y | A-Y | A-Y | From April 2013 First three characters denote owning Clinical Commissioning Group e.g. 11AAA - 99YZZ | |||||
Dispensary | F | F | A-Y | A-9 | 0-9 | 0-9 | e.g. FA002 | |||||
Executive Agency Site | N/A | X | 0-9 | 0-9 | 0-9 | 0-9 | First three characters denote Executive Agency e.g. X0901 | |||||
Government Department Site | B | X | A-Y | A-Y | 0-9 | 0-9 | First three characters denote Government Department e.g. XDA01 | |||||
GP Practice Branch Surgery - England and Wales | D | A-H, | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | 0-9 | First 6 characters denote parent practice. Char 1 = W for Welsh GP Practice. All other values represent English GP Practices e.g. H81010002 | |
C | A, B, D, G, I, K, L, M , N, O, S, U, V, W | A-Y | A-Y, 0-9 | A-Y, 0-9 | A-Y, 0-9 | First three characters denote owning Independent Sector Healthcare Provider (ISHP) e.g. NV701 Note: The A-Y range includes all letters except Z | ||||||
Local Authority (LA) Site | G | V | A-9 | A-9 | A-9 | A-Y | A-Y | First four characters denote LA e.g. V001AA | ||||
Local Health Board (Wales) Site | B | 7 | A-9 | A-9 | A-9 | A-9 | First three characters denote owning NHS Trust e.g. 7A101 | |||||
Local Service Provider (LSP) Site | A | L | S | P | 0-9 | 0-9 | 0-9 | 0-9 | First five characters denote owning Local Service Provider e.g. LSP0101 | |||
NHS Trust Site | B | R | A-9 | A-9 | A-9 | A-9 | First three characters denote owning NHS Trust e.g. RH802 | |||||
I | T | P or Q | 0-9 | A-9 | A-9 | e.g. TP01A, TQ01A | ||||||
Other Statutory Authority (OSA) Site | B | X | 0-9 | 0-9 | 0-9 | 0-9 | First three characters denote owning Other Statutory Authority e.g. X1601 | |||||
Primary Care Trust (PCT) Site | B | 5 | A-9 | A-9 | A-9 | A-9 | First three characters denote owning Primary Care Trust e.g. 5CT49 | |||||
Prison | H | Y | D | E | A-9 | A-9 | e.g. YDE01 | |||||
Special Health Authority (SpHA) Site | E | T | 1 | 0-9 | 0-9 | A-Y, 1-9 | First three characters denote owning SpHA e.g. T115A | |||||
Strategic Health Authority (SHA) Site | B | Q | A-9 | A-9 | A-9 | A-9 | First three characters denote owning SHA Trust e.g. Q3001 | |||||
Treatment Centre | B | 5, | A-9 | A-9 | A-9 | A-9 | First three characters denote owning NHS Trust, PCT or Private Healthcare Provider e.g. 5CG12, NT501, RBFTC | |||||
|
|
|
|
|
|
| ||||||
B | 6 | A-Y | 0-9 | A-9 | A-9 | First three characters denote owning Local Health Board (Wales) e.g. 6C4A1 All Welsh Local Health Board Sites closed on 30 September 2009 Local Health Board Sites introduced from 1 October 2009 |
Note: Codes for Executive Agency, Executive Agency Programme, Executive Agency Site and Executive Agency Programme Department do not easily fit into the coding frames as shown above and are therefore not included. This is due to their unusual structure in that there are more hierarchical 'tiers' than with other organisations.
Executive Agency and Executive Agency Programme are both considered Organisation level entities, although each Programme does have a relationship to an Executive Agency. Executive Agency codes are three characters long. Executive Agency Programme codes are six, and their first three characters are the same as the Executive Agency they are associated to.
Department codes of eight characters long can then be allocated underneath a Programme code (sharing the first six characters). Executive Agency Site codes of five characters long can be allocated under an Executive Agency code (and share the first three characters).
Note: A-9 indicates that characters A-Z and 0-9 are valid: except B, I, O, S, U and Z (to avoid ambiguity). This applies to all ORGANISATION SITE CODES in the Coding Format Table above except Independent Sector Healthcare Provider (ISHP) sites.
Table 2: CODING FORMATS FOR ORGANISATION SITES IN OTHER HOME COUNTRIES
ORGANISATION SITE CODES for Isle of Man Government Departments, Directorates and Sites are published by the Organisation Data Service and can be found:
- on their website at: http://nww.connectingforhealth.nhs.uk/ods/downloads/iomdown for NHS staff only and
- via files issued on the Technology Reference Data Update Distribution Service (TRUD) website.
Organisation Type | Character Position | Code allocated by: | Notes/Comments | ||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |||
Y | K | A-9 | A-9 | A-9 | First three characters denote parent IOM Directorate e.g. YK101 |
Note: A-9 indicates that characters A-Z and 0-9 are valid: except B, I, O, S, U and Z (to avoid ambiguity).
Change to Attribute: Changed Description
The type of PATIENT diagnosis provided as a result of an NHS Health Check Assessment.The type of PATIENT DIAGNOSIS provided as a result of an NHS Health Check Assessment.
National Codes:
01 | Chronic Kidney Disease Stage 3 |
02 | Chronic Kidney Disease Stage 4 |
03 | Chronic Kidney Disease Stage 5 |
04 | Type 2 Diabetes |
05 | Hypertension |
06 | Non Diabetic Hyperglycaemia |
Change to Data Element: Changed Name, status to Retired, Description
ABSENCE WITHOUT LEAVE END DATE is the end date of a period of Mental Health Absence Without Leave for a PATIENT detained under the Mental Health Acts 1983.This item has been retired from the NHS Data Model and Dictionary and it is no longer required for the Mental Health Minimum Data Set.
The last live version of this item is available in the September 2012 release of the NHS Data Model and Dictionary.
Access to this version can be obtained by emailing datastandards@nhs.net with "NHS Data Model and Dictionary - Archive Request" in the email subject line.
Change to Data Element: Changed Name, status to Retired, Description
- Changed Name from Data_Dictionary.Data_Field_Notes.A.ABSENCE_WITHOUT_LEAVE_END_DATE to Retired.Data_Dictionary.Data_Field_Notes.A.ABSENCE_WITHOUT_LEAVE_END_DATE
- Retired ABSENCE WITHOUT LEAVE END DATE
- Changed Description
Change to Data Element: Changed Name, status to Retired, Description
ABSENCE WITHOUT LEAVE START DATE is the Start Date of a period of Mental Health Absence Without Leave for a PATIENT detained under the Mental Health Acts 1983 as amended by the Mental Health Act 2007.This item has been retired from the NHS Data Model and Dictionary and it is no longer required for the Mental Health Minimum Data Set.
The last live version of this item is available in the September 2012 release of the NHS Data Model and Dictionary.
Access to this version can be obtained by emailing datastandards@nhs.net with "NHS Data Model and Dictionary - Archive Request" in the email subject line.
Change to Data Element: Changed Name, status to Retired, Description
- Changed Name from Data_Dictionary.Data_Field_Notes.A.ABSENCE_WITHOUT_LEAVE_START_DATE to Retired.Data_Dictionary.Data_Field_Notes.A.ABSENCE_WITHOUT_LEAVE_START_DATE
- Retired ABSENCE WITHOUT LEAVE START DATE
- Changed Description
Change to Data Element: Changed Description
Notes:This is the TREATMENT FUNCTION under which the PATIENT is treated. It may be the same as the MAIN SPECIALTY CODE or a different TREATMENT FUNCTION which will be the CARE PROFESSIONAL's treatment interest.This item is being used for development purposes and has not yet been assured by the Information Standards Board for Health and Social Care.
Midwife Episodes and Nursing Episodes may use any appropriate ACTIVITY TREATMENT FUNCTION CODE.
The pseudoCONSULTANTMAIN SPECIALTY CODEof950 'Nursing Episode'(forNURSES) must only be used forCARE PROFESSIONAL MAIN SPECIALTY CODE, seeMAIN SPECIALTY CODE.TheMAIN SPECIALTY CODE560 'Midwife Episode'can be used both as aMAIN SPECIALTYand aTREATMENT FUNCTION.
The default codes 199 and 499 are only applicable for overseas health care providers.
ACTIVITY TREATMENT FUNCTION CODE replaces TREATMENT FUNCTION CODE, and should be used for all new and developing data sets and for XML messages.
Change to Data Element: Changed Description
Format/Length: | See DATE |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:ASSESSMENT DATE (FOR TRANSPLANT SUITABILITY) is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TIME TYPE is National Code 'Assessment Date For Transplant Suitability'.ASSESSMENT DATE (FOR TRANSPLANT SUITABILITY) is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Assessment Date For Transplant Suitability'.
Change to Data Element: Changed Description
Format/Length: | an35 |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:
CDS RECORD IDENTIFIER may also be referred to as the CDS-RID.
When exchanging Commissioning Data Set data, this is an optional data element and when used is a unique number generated by the sender and inserted into the Commissioning Data Set data to enable senders and recipients to be able to cross-match and uniquely identify each and every Commissioning Data Set record.
The CDS RECORD IDENTIFIER consists of the following components:
REF | RID COMPONENT | FORMAT | CODES / VALUES |
---|---|---|---|
1 | CDS SENDER IDENTITY | an5 | As generated in the CDS V6-2 Type 005B - CDS Transaction Header Group - Bulk Update Protocol or the CDS V6-2 Type 005N - CDS Transaction Header Group - Net Change Protocol |
2 | Not Used | an2 | Set = Blank |
3 | CDS INTERCHANGE CONTROL REFERENCE | an14 (n7) * | As generated in the CDS V6-2 Type 001 - CDS Interchange Header |
4 | CDS MESSAGE REFERENCE | an14 (n7) * | As generated in the CDS V6-2 Type 003 - CDS Message Header |
* This data item is configured as an14 format element, but a maximum value of 9999999 is permitted in the format of n7.
Usage:
The CDS-RID is an optional reference assigned to each record by the Commissioning Data Set sender to aid the identification and cross-referencing of data between the sender and the receiver(s) of the Commissioning Data Set data.CDS-XML Interchanges:
The CDS-RID data element is carried in the CDS Message Header (CDS V6-2 Type 003 - CDS Message Header).Change to Data Element: Changed Description
Format/Length: | n2 |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:This indicates whether a Central Information Requirement Data Set and the data it contains is a submission from the ORGANISATION in the role of commissioner of care or provider of care.
Permitted National Codes:
01 | Commissioner submission |
02 | Provider submission |
Change to Data Element: Changed Description
Format/Length: | an17 |
HES Item: | |
National Codes: | |
Default Codes: | 8 (left justified padded with spaces) - Not applicable 9 (left justified padded with spaces) - Not known |
COMMISSIONER REFERENCE NUMBER is the same as attribute COMMISSIONER REFERENCE NUMBER.
Change to Data Element: Changed Description
Format/Length: | an6 |
HES Item: | CSNUM |
National Codes: | |
Default Codes: |
Notes:
From 01/04/2001 this data item will be used to identify PATIENTS treated under Non-Contract Activities. NHS Trusts are required to insert the letters 'OAT' (mandated input as capitals) in the first three characters of the COMMISSIONING SERIAL NUMBER field of the Admitted Patient Care Commissioning Data Set. The remaining three characters will continue to be defined locally, see Data Set Change Notice 17/2000.
From 01/04/2005 an '=' (equals) as the last significant character in this six character field will indicate an episode that should be excluded from the Payment by Results tariff. The position of the last character depends on any preceding characters eg 1st character if field is otherwise blank, 4th character if following 'OAT', up to a maximum of 6th position. This provides a general exclusion facility for unusual circumstances or where more specific rules regarding coding in other fields cannot be implemented due to local software restrictions.
Change to Data Element: Changed Description
Format/Length: | See DATE |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:
EARLIEST CLINICALLY APPROPRIATE DATE is the earliest DATE that it was clinically appropriate for an ACTIVITY to take place.
For the Radiotherapy Data Set this is the same as the DECISION TO TREAT DATE unless there was an elective delay.
For the Community Information Data Set and Commissioning Data Sets (version 6-2 onwards), the EARLIEST CLINICALLY APPROPRIATE DATE may be used locally to inform waiting time calculations. It can be used to account for periods of time where it is not appropriate to treat the PATIENT for clinical reasons, for example:
- where the PATIENT has been admitted to hospital for an unrelated condition and the Community Health Service cannot commence planned treatment until the PATIENT has been discharged
- where the PATIENT is frail and cannot be treated until their condition improves, but it is not appropriate to discharge the PATIENT from the Community Health Service.
Change to Data Element: Changed Description
Format/Length: | See TIME |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:
END TIME (SUPERVISED COMMUNITY TREATMENT RECALL) is the same as attribute ACTIVITY TIME where the ACTIVITY TIME TYPE is National Code 'End Time' of the Supervised Community Treatment Recall.
Change to Data Element: Changed Name, status to Retired, Description
See the Clinical Data Sets Menu for a link to the latest version of the data set.
The last live version of this item is available in the September 2012 release of the NHS Data Model and Dictionary.
Access to this version can be obtained by emailing datastandards@nhs.net with "NHS Data Model and Dictionary - Archive Request" in the email subject line.
Change to Data Element: Changed Name, status to Retired, Description
- Changed Name from Data_Dictionary.Data_Field_Notes.L.LEAVE_OF_ABSENCE_END_DATE to Retired.Data_Dictionary.Data_Field_Notes.L.LEAVE_OF_ABSENCE_END_DATE
- Retired LEAVE OF ABSENCE END DATE
- Changed Description
Change to Data Element: Changed Name, status to Retired, Description
See the Clinical Data Sets Menu for a link to the latest version of the data set.
The last live version of this item is available in the September 2012 release of the NHS Data Model and Dictionary.
Access to this version can be obtained by emailing datastandards@nhs.net with "NHS Data Model and Dictionary - Archive Request" in the email subject line.
Change to Data Element: Changed Name, status to Retired, Description
- Changed Name from Data_Dictionary.Data_Field_Notes.L.LEAVE_OF_ABSENCE_START_DATE to Retired.Data_Dictionary.Data_Field_Notes.L.LEAVE_OF_ABSENCE_START_DATE
- Retired LEAVE OF ABSENCE START DATE
- Changed Description
Change to Data Element: Changed Description
Format/Length: | an1 |
HES Item: | OPERSTAT |
National Codes: | |
Default Codes: |
Notes:
OPERATION STATUS CODES should be used once for each record to record states of knowledge regarding the operative procedure.
This item is being used for development purposes and has not yet been assured by the Information Standards Board for Health and Social Care.Permitted National Codes:
1 | One or more operative procedure carried out |
8 | Not applicable i.e. no operative procedures performed or intended |
9 | Not known i.e. finished episode/out-patient attendance but no data entered or the episode is unfinished and no data needs to be present. This would be a validation error only for a finished episode |
If it is not intended to perform a procedure at the future attendance, use value 8. Otherwise this data element should be omitted.
OPERATION STATUS CODE replaces OPERATION STATUS and should be used for all new and developing data sets and for XML messages.
Change to Data Element: Changed Description
Format/Length: | 7 alphanumeric characters |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:
Change to Data Element: Changed Description
Format/Length: | See DATE |
HES Item: | DOB |
National Codes: | |
Default Codes: |
Notes:
PERSON BIRTH DATE is the same as attribute PERSON BIRTH DATE.
This is the e-Government Interoperability Framework (e-GIF) standard that should be used for all new and developing systems and for XML messages.
Change to Data Element: Changed Description
Format/Length: | See PERSON BIRTH DATE |
HES Item: | DOBBABY |
National Codes: | |
Default Codes: |
Notes:
PERSON BIRTH DATE (BABY) is the same as data element PERSON BIRTH DATE for the baby.
Change to Data Element: Changed Description
Format/Length: | See PERSON BIRTH DATE |
HES Item: | MOTDOB |
National Codes: | |
Default Codes: |
Notes:
PERSON BIRTH DATE (MOTHER) is the same as data element PERSON BIRTH DATE for the mother.
Change to Data Element: Changed Description
Format/Length: | max n3.n1 |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:
PERSON HEIGHT IN CENTIMETRES records the Height of the PERSON in centimetres.
Change to Data Element: Changed Description
Format/Length: | n1.max n2 |
HES Item: | |
National Codes: | |
Default Codes: |
Notes:
PERSON HEIGHT IN METRES records the Height of the PERSON in metres.
This corresponds to MEASURED OBSERVATION VALUE where the MEASURED PERSON OBSERVATION TYPE CODE is 'Height' and MEASUREMENT VALUE TYPE CODE is 'Metres'.
For the Systemic Anti-Cancer Therapy Data Set, PERSON HEIGHT IN METRES is the Height at the start of the Systemic Anti-Cancer Drug Regimen.
Change to Package: Changed Name
- Changed Name from Data_Dictionary.Attributes.N.NE to Data_Dictionary.Attributes.N.Ne
Change to Package: Changed Name
- Changed Name from Data_Dictionary.Data_Field_Notes.O.Of to Data_Dictionary.Data_Field_Notes.O.Oc
For enquiries, please email datastandards@nhs.net